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Soyasaponins are found in soy (Glycine max) and other legumes such as green peas 
(Pisum sativum L) and lentils (Lens culinaris) (Ruiz, Price et al. 1996; Daveby, Aman et al. 
1998; Yoshiki, Kudou et al. 1998). Soyasaponins are oleanane triterpenoid glycosides 
possessing complex and diverse structures. They are amphiphilic molecules with polar water 
soluble sugar moieties attached to a nonpolar, water insoluble pentacyclic ring structure. 
Soyasaponins are categorized according to the individual aglycones (soyasapogenols) and 
there are two main aglycones referred to as group A and group B.  
Soyasaponins have recently gained more attention because of their bioactivities. There 
are many reports relating the bioactive benefits of soyasaponins to their structures (Kitagawa, 
Yoshikawa et al. 1982; Gurfinkel and Rao 2003; Wink 2008; Zhang and Popovich 2009), 
such as their potential health-promoting functions, enzyme-altering activity, antimutagenic 
activity, antiviral activity, hepatoprotective effects, interaction with bile acids, cancer 
chemopreventaton (Ruiz, Price et al. 1996; Daveby, Aman et al. 1998) and cholesterol 
lowering properties (Yoshiki, Kudou et al. 1998). However, the chemical characteristics of 
soyasaponins have not been fully identified due to the complex structure, overlap polarities, 
artifacts (Zhang and Popovich 2009) and labor intensive purification, isolation and analysis 
of these compounds (Kitagawa, Yoshikawa et al. 1982; Shiraiwa, Harada et al. 1991). There 
are also a few reports in the literature relating to the bioactivity of specific soyasaponins.  
Thus, in this thesis, the bioactivities of the total soyasaponins, group B soyasaponins 
(DDMP-conjugated and Non-DDMP conjugated) and their aglycones soyasapogenol A and B 
were assessed in cultured human liver cancer cells (Hep-G2). The overall results indicate 
 2 
apoptosis cell death is the main route of soyasaponins treated cell death with one exception of 
the room temperature extracted group B soyasaponins (RT). RT samples caused Hep-G2 cells 
to differentiate and slowed the growth of cells without any significant cytotoxicity. In 
addition, a reliable method for isolation, chemical characterization, purification and detection 
of soyasaponins were developed. Soyasaponins extraction, isolation and detection factors 
such temperature, solvent system and time were optimized. Enzyme fermentation was 
utilized to modify soyasaponins structures in order to investigate whether fermentation 
enhanced bioactivities.  
The evidence presented in this thesis shows soyasaponins have strong bioactivities on 
cultured liver cancer cells and have potential for developing nature healthy product in the 
future. However, the specific mechanism of action of specific soyasaponins on cells death 
requires more research. Furthermore achieving high purity soyasaponins (>90%) remains one 








CHAPTER 1 INTRODUCTION  
1.1 BASI C KNOWLEDGE OF SOYASAPONINS  
From a chemical standpoint, soyasaponins are made up of three entities: aglycones 
(steroid or triterpene), sugars and sometimes acids. Up to now, a variety of triterpene 
saponins have been isolated from soybeans. Depending on the nature of triterpene aglycones, 
soyasaponins are divided into three categories, group A, B and E (Figure 1). Group A 
consists of bidesmosidic glycosides of soyasapogenol A. Group B consists of 
monodesmosidic glycosides of soyasapogenol B and are thought to be the more abundant 
group of soyasaponins in soy (Shiraiwa, Harada et al. 1991). A third soyasaponin aglycone, 
soyasapogenol E (the aglycone of group E), has a ketone at position C22 and has been 
reported to be formed during soy extraction (Kitagawa, Yoshikawa et al. 1982; Tsukamoto, 
Kikuchi et al. 1992; Gurfinkel and Rao 2003; MacDonald, Guo et al. 2004). Group E 
soyasaponins Bd and Be have been reported to be transformed into group B aglycone during 
acid hydrolysis (Rupasinghe, Jackson et al. 2003) thus suggesting that group E aglycone 
might be artifacts formed during alcoholic soyasaponin extraction (Ireland and Dziedzic 1986) 
and not naturally found. However, in this study, I still consider group E as an individual 
group of soyasaponins.  
Two different naming conventions for main soyasaponins groups A and B, are currently 
utilized in the literature which adds to the complexity of summarizing and interpreting the 
reported literature (Kitagawa, Yoshikawa et al. 1982; Kitagawa, Saito et al. 1985; Shiraiwa, 
Harada et al. 1991; Yoshiki, Kudou et al. 1998) and both conventions are shown in Figure 1. 
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1.2 OBJECTIVES OF THESIS  
Overall Aim 
The overall aim of this thesis is to investigate and optimize methods to isolate, quantify, 
detect and transform soyasaponins for bioactive evaluation 
Specific Objectives 
1. To develop a crude extract that contains a quantifiable amount of soyasaponins. 
(Chapter 3) 
2. To hydrolyze the crude extract to produce an extract consisting mostly of 
soyasapogenols (Chapter 3) 
3. To measure the bioactive response of cultured hepatocarcinoma a cells (Hep-G2) to 
crude soyasaponins extract and the soyasapogenol extract (Chapter 3)  
4. To investigate the effect of extraction conditions on soyasaponin profile and bioactive 
responses in Hep-G2 cells (Chapter 4) 
5. To measure the level of apoptosis which induced by soyasaponins I and III extracts on 
Hep-G2 cells (Chapter 5) 
6. To develop a method to prepare a soyasaponin extract that has a majority of saponins 
as soyasaponin I and III (Chapter 6) 
7. To optimize the MS conditions for the analysis and behavior of Soyasapogenol B 
(Chapter 7) 




CHAPTER 2 LITERATURE REVIEW 
Preface 
Selected portions of Chapter 2 have been published in the following publications 
Zhang W and Popovich DG (2009). "Chemical and Biological Characterization of Oleanane 
Triterpenoids from Soy." Molecules 14(8): 2959-2975. (Review Paper)  
 
Zhang W and Popovich DG (2010) Bioactivity of Oleanane Triterpenoids from Soy 
(Glycine max Merr) Depends on the Chemical Structure in "Legumes": Properties, 
Consumption and Nutrition. Nova Science Publishers, accepted 
2.1 SOYASAPONIN CLASSIFICATION 
Soyasaponins are categorized according to the individual aglycones (soyasapogenols) and 
there are two main aglycones referred to as group A and group B. Group A soyasaponins 
(Figure 1) are bidesmosidic saponins with two glycosylation sites at carbons 3 and 22 on the 
oleanane ring structure. Group A soyasaponins can be divided into two groups known as 
acetylated and deacetylated forms (Kitagawa, Saito et al. 1985; Shiraiwa, Harada et al. 1991). 
Group B soyasaponins have one glycosylation site on their aglycones (carbon 3) and are also 
classified into 2 groups based on the conjugation at carbon 22 with a DDMP (2,3-dihydro-2,5- 
dihydroxy -6-methyl- 4-pyrone) moiety and non-DDMP conjugated soyasaponins. DDMP 
conjugated soyasaponins are known as αg, βa, βg, γa and γg, and non-DDMP conjugated 
soyasaponins are known as soyasaponins I, II, III, IV and V (Shiraiwa, Harada et al. 1991; 
Kudou, Tonomura et al. 1992; Kudou, Tonomura et al. 1993). DDMP group B soyasaponins 
are thought to be the more abundant group of soyasaponins in soy (Shiraiwa, Harada et al. 
1991). There are two different naming conventions currently utilized in the literature which 
adds to the complexity of summarizing and interpreting the reported literature (Kitagawa, 
Yoshikawa et al. 1982; Kitagawa, Saito et al. 1985; Shiraiwa, Harada et al. 1991; Yoshiki, 
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Kudou et al. 1998) and both conventions are shown in Figure 1. A third soyasaponin aglycone 
known as group E which has a ketone at position C22 and has been reported to be formed 
during soy extraction (Kitagawa, Yoshikawa et al. 1982; Tsukamoto, Kikuchi et al. 1992; 
Gurfinkel and Rao 2003; MacDonald, Guo et al. 2004). Group E soyasaponins Bd and Be have 
been reported to be transformed into group B aglycone during acid hydrolysis (Rupasinghe, 
Jackson et al. 2003) thus suggesting that group E aglycone might be an artifacts formed during 
alcoholic soyasaponin extraction (Ireland and Dziedzic 1986) and not naturally found.  
Soyasaponins are thought to be bioactive molecules, and there are many reports relating 
the bioactive response to the soyasaponin structure (Kitagawa, Yoshikawa et al. 1982; 
Gurfinkel and Rao 2003; Wink 2008; Zhang and Popovich 2009). In this chapter, the isolation, 
chemical characterization and detection strategies focusing on HPLC and LC-MS to analyze 
soyasaponins will be discussed along with the reported bioactive effects of soyasaponins 




Figure 1. The chemical structures and molecular weights of soyasaponins. DDMP refers 
to 2,3-dihydro-2, 5-dihydroxy-6-methyl-4H-pyran-4-one (DDMP), glc , β-D-glucopyranosyl; 
gal, β-D-galactopyranosyl; glcUA, β-D-glucuronopyranosyl; ara, α-L-arabinopyranosyl; rha, 
α-L-rhamnopyranosyl; xyl, β-D-xylopyranosyl; MW, molecular weight. Columns numbered 1 
and 2 refer to the different naming conventions (Kitagawa, Saito et al. 1985; Shiraiwa, Harada 
et al. 1991). 
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2.2 SOYASAPONIN EXTRACTION  
Although scientific reports on soyasaponins have been around for at least 80 
years(Sumniki 1929), the extraction, purification and quantification still presents many 
challenges. Soyasaponin glycosides are structurally similar and can possess overlapping HPLC 
retention times, similar molecular mass and fragmentation patterns when analyzed using mass 
spectrometer (MS); furthermore some soyasaponins such as the group B DDMP conjugated are 
heat labile (Ochiai, Tsuda et al. 1937; Kudou, Tonomura et al. 1993; Hu, Lee et al. 2002) 
confounding authentic saponin identification and quantification. The purification process is 
complex and laborious with long sample preparation and extraction times and yielding 
relatively low amounts of soyasaponins from soy (Yoshiki, Kudou et al. 1998). The amount of 
soyasaponins found in soy and related products are generally between 1.8% and 4.4%, 
depending on the variety and cultivation conditions of the soybean (Yoshiki, Kudou et al. 
1998). The lack of a full complement of available commercial soyasaponin standards (Zhang, 
Teng et al. 2009) has slowed the pace of research. Many of the current studies on soyasaponins 
have focused on extraction and analysis usually producing relatively low yields and in 
insufficient quantities for biological activity testing of individual compounds. 
Conventional extractions and preparation of soyasaponins from defatted soy flour or soy 
products typically involves the use of organic solvents usually either aqueous ethanol or 
methanol with agitation at room temperature. Room temperature extraction can prevent the 
breakdown of the DDMP conjugated compounds and most of the sugar glycoside molecules 
(Decroos, Vincken et al. 2007). The extraction efficiency is dependent on three main factors, 
time, temperature (both ambient and solvent temperature) and choice of solvents (Ochiai, 
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Tsuda et al. 1937; Hu, Lee et al. 2002; Tava, Mella et al. 2003; Zhang, Teng et al. 2009). The 
optimum extraction time has been reported to be between 4 to 6 h for the maximum yield of 
soyasaponins from soy flour using absolute methanol at 60 
o
C under reflux (Gu, Tao et al. 
2002). Thermal energy likely transformed DDMP conjugated group B soyasaponins such as g 
into in the corresponding non-DDMP soyasaponin I (Kudou, Tonomura et al. 1993). A similar 
funding was also reported for the dammarane triterpenoids saponins from ginseng (Panax 
quinquefolius) extracted in boiling water (Gurfinkel, Reynolds et al. 2005).  
2.3 SOYASAPONIN EXTRACT PREPARATION 
The basic extraction methodology used to extract soyasaponin typically involved 
preparing crude extracts then employing a column chromatography concentration followed by 
purification and separation of individual soyasaponins (Ochiai, Tsuda et al. 1937; Tava, Mella 
et al. 2003; Zhang, Teng et al. 2009). However, soyasaponins are not the only biologically 
active groups of molecules found in soy and related products. Soy’s biological actively can be 
attributed to three main classes of compounds, soy protein, isoflavones and the soyasaponins. 
Soy protein can be easily and selectively removed by ammonium acetate precipitation, 
however the isoflavones and the soyasaponins share overlapping polarities making separation, 
quantification, and assessment of bioactivity difficult (Hu, Lee et al. 2002). Employing 
column chromatography has been reported to be successful in separating the isoflavones from 
the soyasaponins. Decroos et al.(Decroos, Vincken et al. 2007) utilized an ethanol conditioned 
XAD-2 column to concentrate soyasaponins and isoflavones in defatted soy hypocotly 
followed by fractioning and purification using preparative scale reverse phase chromatography 
(Decroos, Vincken et al. 2007). The preparative chromatographic approach was shown to be 
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effective in separating the isoflavones from the soyasaponins based on different retention 
times, as the isoflavones were reported to elute earlier than the soyasaponin (Decroos, Vincken 
et al. 2007). However, the purity of individual soyasaponins Ab, αg and βg were not optimal 
and required a second chromatographic step (Decroos, Vincken et al. 2007). Preparative 
HPLC is an effective procedure to separate individual soyasaponins but it is hampered by the 
large amount solvent needed and the low recovery yield. Semi-preparative purification have 
also been successfully utilized for soyasaponin purification (Gu, Tao et al. 2002). 
Alternatively, utilization of solid phase extraction has been reported to be a simple and 
economical alternative to achieve relatively pure soyasaponins between 85-90% (Gurfinkel, 
Reynolds et al. 2005). In addition, a concentration of 50% methanol was found to be the 
optimum to separate the group B soyasaponins from the isoflavones, using SPE, virtually 
removing all but less than 1% of the isoflavones (Decroos, Vincken et al. 2007). 
2.4 ANALYSIS AND DETERMINATION OF SOYASAPONINS 
There are various reported methods for the determination of soyasaponins from soy and 
soy products. Separation with thin layer chromatography and quantification using a 
densitometer has been reported as an economical and effective way to separate and quantify 
soyasaponins (Gurfinkel and Rao 2002). High-performance liquid chromatography (HPLC) 
utilizing a reversed-phase column is the most prevalent analytical technique for soyasaponins 
analysis. Various detectors have been used such as ultra violet or photo diode array (PDA) 
(Kudou, Tonomura et al. 1992; Hu, Lee et al. 2002; Hubert, Berger et al. 2005), and 
evaporative light scattering detection (ELSD) (Rupasinghe, Jackson et al. 2003; Ganzera, 
Stuppner et al. 2004). The maximum absorption wavelength of most of soyasaponins is a about 
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205 nm (Gu, Tao et al. 2002), while some of the DDMP soyasaponins can reach 295 nm. Due 
to the large number of soyasaponin glycosides found in soy, the development of an all 
encompassing UV detection method is difficult to achieve (Hubert, Berger et al. 2005) and 
often two different gradients programs are utilized to achieve full soyasaponin detection. An 
analytical method using UV was reported for the detection of all the known group B 
soyasaponins at a wavelength of 205 nm provided standards have been prepared in advance 
(Hu, Lee et al. 2002). ELSD, which is based on mass detection by light scattering after 
evaporation of the mobile phase, has been successfully used for the detection of 
soyasapogenols, soyasaponins and ginseng saponins (Decroos, Vincken et al. 2005). ELSD 
has been successfully reported to be able to detect the authentic soyasapogenols (Rupasinghe, 
Jackson et al. 2003). However, ELSD like UV, has some disadvantages such as an extensive 
sample preparation and potential interference when detecting low quantities in serum (Yang, 
Jin et al. 2007). Often one solvent gradient program is optimized to separate the more abundant 
soyasaponin glycosides and one is optimized for the separation of the soyasapogenols leading 
to a time consuming analysis (Zhang and Popovich 2008; Zhang, Teng et al. 2009). Tables 1 
and 2 lists the various HPLC analysis strategies employed in the recent literature to detect the 







Table 1. HPLC Quantification Methods of Soyasaponins 
Concentration 
Method 
Group A Group B Column Group A Solvent Program Group B Solvent Program 
XAD-2 
(Decroos, 








Source 15 RP Gradient 
A: Water with 0.001% acetic 
acid (v/v); 
B: Acetonitrile with 0.001% 
acetic acid (v/v) 
Gradient 
A: Water with 0.001% acetic acid (v/v); 
B: Acetonitrile with 0.001% acetic acid (v/v) 
Silica gel (Gu, 
Tao et al. 2002) 





Methanol, 2-propanol, water 
and formic acid (45:5:50:0.1) 
(v/v) 
Isocratic 






et al. 2006) 





Acetic acid, acetonitrile, and 
water (1:30:69) (v/v).  
Gradient 
A: 100% Acetonitrile 
B: Water 
Pre-equilibrated 





SPE (Zhang and 
Popovich 2009; 
Zhang, Teng et 
al. 2009) 
All All SPE Water and Methanol Water and Methanol 
C18 Lobar 
column (Hu, 
Lee et al. 2002) 





Acetonitrile, water, TFA (40:59.95:0.05) (v/v)  
NON-DDMP: 
Acetonitrile, water, TFA (36:63.95:0.05) (v/v) 
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C18 Cartridge 
(Jin, Yang et al. 
2006) 










A: 0.025% AcOH in water (v/v); 
B: 0.025% AcOH in MeCN (v/v) 
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Table 2. Quantification Methods for Soyasapogenol A and B 
 
Compound MW Formula Analytic Method Solvent System and Program Specification 
Soyasapogenol 
A 
474 C30H50O4 TLC (Ireland and 
Dziedzic 1985) 
Silica gel 60G 
Light petroleum (b.p. 60-80
o
C), ethyl 
acetate (4:3) (v/v) 
Visualization 10% sulfuric acid in ethanol 
and viewing under UV 
   TLC (Berhow, 
Cantrell et al. 2002) 
Dichloromethane and methanol (9:1) 
(v/v) 
Spraying with a saturated solution of 
potassium dichromate in sulfuric acid 
   Normal phase 
HPLC (Ireland and 
Dziedzic 1985) 
A: Light petroleum (b.p. 60-80
o
C); B: 
Ethanol, 0-7.5min, 0-7.5% B; 7.5-15 
min, 7.5% B isocratic; 15-20 min, 
7.5-20% B  
Silica Column (250mm x 4.6mm) 
Flow-rate 1.5 mL/min 
Soyasapogenol 
B 
458 C30H50O3 Revised HPLC 
(Rupasinghe, 
Jackson et al. 2003) 
Acetonitrile: 1-propanol: water: 0.1% 
acetic acid (80:6:13.9:0.1) (v/v) 
Isocratic 
ODS C18 column (250mm x 4.6mm) 
Flow-rate 0.9mL/min 
ELSD detection 
   Revised HPLC 
(Hubert, Berger et 
al. 2005) 
A: Acetonitrile: 1-propanol: water: 
acetic acid (80:6:13:0.1) (v/v);  
B: 100% Acetonitrile 
0-15 min 100% A isocratic; 15-17 min 
0-100% B; 17-19 min 100% B; 19-22 
min back to 100% A 
RP-C18-AB column (250 x 4.6 mm) 
Flow-rate 0.9 mL/min 
 15 
    Identification of the soyasaponins of interest typically requires MS analysis either as part 
of HPLC-MS system or as an individual MS to confirm the molecular weight. HPLC-MS 
detection seems to be most relevant and effective method for the identification of soyasaponins 
(Jin, Yang et al. 2006), other triterpenoids (Popovich and Kitts 2004) and specifically group B 
soyasaponins (Berhow, Cantrell et al. 2002; Jin, Yang et al. 2006). Decroos et al. (Decroos, 
Vincken et al. 2005) developed an HPLC-ELSD-ESI-MS method for analysis all groups of 
soyasaponins including acetyl soyasaponins group A and DDMP group B soyasaponins. MS 
detection of oleanane triterpenoids is complex and require experienced personnel, expensive 
equipment which is usually not available for daily routine analysis in many laboratories (Hu, 
Zheng et al. 2004). Complicated fragmentation patterns are produced during ionization 
resulting in molecular weight confirmation issues. Heftmann et al. (Heftmann, Luudin et al. 
1979) reported oleanane triterpenoid ring structures of the soyasapogenols are itself prone to 
fragmentation due to a reverse Diels-Alder reaction. MS analysis of the soyasapogenols can be 
challenging to interpret. For example, soyasapogenol A have been reported to produced a 
fragmentation pattern with the most abundant ion in positive mode corresponding to molecular 
weight of 250, while and soyasapogenol B fragment ion was 234 (Heftmann, Luudin et al. 
1979). These two fragment are caused by the reverse Diels-Alder reaction and correspond to 
molecular weight of 474 and 458 of the respective soyasapogenols (Heftmann, Luudin et al. 
1979). Soyasapogenol fragmentation and breakdown during ESI analysis of group B 
soyasaponins was avoided by carefully adjusting the fragmentation temperature and generally 
keeping the internal temperature below 250C. Table 3 summarizes the recent literature on the 
detection and use of HPLC-MS technique for soyasaponin analysis.  
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Table 3. LC-MS Analysis of Soyasaponins 
LC-MS System LC-MS LC 
Program 






Trap SL (Jin, Yang 
et al. 2007) 
Waters AccQ.Tag 
column 
A: 0.025% AcOH 
in water (v/v) 
B:0.025% AcOH 































Waters 2690 liquid 
chromatograph 
with a Waters 996 
PDA (Dalluge, 




A: Water with 
0.05% TFA (v/v) 
B: ACN with 


















Group A: Ab, Ac, 
Af 




Ab, Af  
Tri-deacetyl Ad  
Group B: Ba, Bb, 
Bb′, Bc, Bc 
DDMP Bb, Bc, 
Ba 
Agilent LC/MSD 
Trap SL (Jin, Yang 
et al. 2006) 
Waters AccQ.Tag 
column 
A: 0.025% acetic 
acid in water (v/v) 
B: 0.025% acetic 
























Group A: Aa-Af 
Group B: Bb, 
Bb’, Bd and Be 




Trap SL (Yang, Jin 
et al. 2007) 
The same as (Jin, 










Group A: Aa, Ab 









Waters HPLC with 
Finnigan LCQ 
quadrupole ion 
trap MS with MSn 





A: 2.5% acetic 





















Full Scan Group B: I, III,  
DDMP βg, βa, 
γg, γa 
Group E: Be 
Bruker Esquire LC 
with ESI-MS 
system (Huhman, 






0.1% acetic acid 
in water and 
acetonitrile 95:5 


























with a Micromass 
Mass spectrometer 





A: 0.2% formic 
acid in water (v/v) 
B: 0.2% formic 




















Group A: Aa, Ab, 
Ac, Ae, Af, Ag 
and Ah 























































Chen et al. 1999) 
Full accelerating voltage of 10 keV 
Resolving power 3 x 10
3 
Xenon was used for providing fast 
atoms 
20 mA discharge current 






Group B: I, II 
and V 
DDMP βg 




Much of the early work on soyasaponins and other triterpenes such as the dammarane 
saponins from ginseng utilized acid or alkaline hydrolysis to deglycosolate the sugar moieties 
of the triterpene leaving for the most part an intact aglycone (Kitts and Popovich 2003). The 
soyasapogenols and related soyasaponins were then separated and visualized on thin-layer 
chromatography (TLC) before and after hydrolysis to confirm the presence of different 
aglycones and to assign new compounds to their respective groups based on TLC migratory 
patterns.   
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Acid hydrolysis is generally the preferred method for preparing soyasapogenols from 
crude soyasaponin extracts (Ireland and Dziedzic 1986; Gurfinkel and Rao 2002; Hu, Zheng et 
al. 2004; Zhang and Popovich 2008). Acid hydrolysis in anhydrous methanol has been reported 
to enable the highest recovery of soyasapogenols A and B without producing artifacts (Ireland 
and Dziedzic 1986; Rupasinghe, Jackson et al. 2003). Moreover, Ireland and Dziedzic (Ireland 
and Dziedzic 1986) showed that methylation for 3 h with 3% sulfuric acid in anhydrous 
methanol produced the greatest yield of soyasapogenols and anhydrous methanol has also been 
shown to increase the yield during acid methanolysis (Rupasinghe, Jackson et al. 2003).  
Alkaline hydrolysis on the other hand, tends to produce partial hydrolysis of 
soyasaponins. Partial alkaline hydrolysis has been reported useful for preparing non-acetylated 
group A soyasaponins and non-DDMP group B soyasaponins (Gu, Tao et al. 2002; Gurfinkel, 
Reynolds et al. 2005). Acetyl group A soyasaponins were reported to converted to non-acetyl 
soyasaponins A1 and A2 during saponification using alkaline treatment. DDMP conjugated 
group B soyasaponins are easily cleaved in alkaline conditions (Kudou, Tonomura et al. 1992; 
Zhang and Popovich 2008; Zhang, Teng et al. 2009) resulting in their corresponding 
non-DDMP molecule. Gurfinkel et al. (Gurfinkel and Rao 2002) found the relative proportion 
of saponified soyasaponins significantly increased after alkaline treatment except for 
soyasaponin III. The DDMP moiety of group B soyasaponins has been found to be cleaved 
from soyasaponins easier than compared to the acetyl groups of group A soyasaponins (Gu, 
Tao et al. 2002).  
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Figure 2. A concentrated Group B soyasaponin extract separated and analyzed by LC-MS 
indicating the intact [M+H]+ fragment corresponding to the molecular weight [18]. 
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2.6 BIOACTIVITIES OF SOYASAPONINS MEASURED IN CELL CULTURE 
The biological activity of each individual saponin is currently unknown, although 
progress on the separation and isolation of sufficient quantities and bioactive testing is being 
made (Ellington, Berhow et al. 2005; Xiao, Huang et al. 2007). Additions of water soluble 
sugar moieties, DDMP and acetyl groups to the soyasaponin structure all affects the polarity 
which may mitigate changes bioactivity (Milgate and Roberts 1995). Many studies have 
shown that mixtures of soyasaponins have measurable bioactivity in cell culture studies. 
Gurfinkel and Rao (Gurfinkel and Rao 2003) reported that there was a relationship between 
structure and bioactivities with soyasapogenols A and B generally being more bioactive 
compared to the glycosides.  
Recent studies have showed that a total soyasaponin extract can inhibit the growth of Hela 
(cervical tumor) cells (Xiao, Huang et al. 2007), and in colon adenocarcinoma cells (HCT-15) 
(Ellington, Berhow et al. 2005; Ellington, Berhow et al. 2006) by inducing programmed cell 
death, either apoptosis or microautophagy. Apoptotic processes removes damaged or mutated 
cells and recycling the cellular components (Kanduc, Mittelman et al. 2002). In Hela cells 
after four days of treatment with a total soyasaponin extract the LC50 was estimated to be 0.4 
mg/mL (Xiao, Huang et al. 2007). In both studies a total soyasaponin extract reduced cell 
growth through the induction of apoptosis. In Hela cells after four days of treatment, total 
soyasaponins (0.4 mg/mL) showed an increase in sub-G1 cells (apoptotic cellular fragments) 
of 10% during cell cycle analysis and 9% in Hep-G2 cells (Xiao, Huang et al. 2007). Xiao et al. 
(Xiao, Huang et al. 2007) also found that soyasaponin treatment reduced mitochondrial 
transmembrane potential and increased the intracellular Ca
2+
 concentration leading to 
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apoptosis (Xiao, Huang et al. 2007). Total soyasaponin extracts have also been reported to 
reduce colon carcinoma cell growth in a number of studies (Sung, Kendall et al. 1995; Sung, 
Kendall et al. 1995; Yoshikoshi, Yoshiki et al. 1996; Koratkar and Rao 1997). Soyasaponin 
were reported to modify the cell membrane of cultured cells (Oh and Sung 2001) potentially 
increasing membrane permeability. Increased membrane permeability has also been reported 
for the dammarane triterpenes derived from ginseng in both cultured leukemia and intestinal 
cells (Popovich and Kitts 2002; Popovich and Kitts 2004).  
Soyasapogenols prepared by acid hydrolysis were reported to inhibit the growth of 
Hep-G2 cells in a dose-dependent manner. The LC50 concentrations were determined to be 
0.05 + 0.01 mg/mL for soyasapogenol A and 0.13 + 0.01 mg/mL for soyasapogenol B (Figure 
3). 
 
Figure 3. The effect of various soyasaponin extracts on hepatacarcinoma cells line (Hep-G2) 
viability after 72 hours of treatment.  
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The composition of the extracts were as follows: SG A contained soyasapogenol A (69.3%), SG B 
contained soyasapogenol B (46.2%), I and III contained 65% soyasaponin I and 29% soyasaponin III, 
Gr B reflux refers to a group B reflux prepared extract that contained I (32.9%), III (14.2%), Be (4.2%), 
βg (28.3%), βa (9.7%), γg (1.7%), < 1% γa and 3% soyasapogenol B, Gr B 25°C refers to a room 
temperature methanolic extract consisting of I (10.4%), III (4.6%), Be (6.2%), βg (46.6%), βa (16.9%), 
γg (4%), γa (1.7%) and < 1%. The TS extract refers to a total soyasaponin extract with an unknown 
saponin composition.(Zhang and Popovich 2008; Zhang, Teng et al. 2009; Zhang, Yeo et al. 2009)  
 
 
Soyasapogenol A inhibited the growth of estrogen-insensitive human breast cancer cells 
(MDA-MB-231) at a concentration of 10 μM but stimulated the proliferation of estrogen 
sensitive cells (MCF-7) 2.5 fold (Rowlands, Berhow et al. 2002). Additionally, the ER-ERE 
DNA complex, a marker of estrogen activation, was induced by soyasapogenol A. 
Soyasapogenol B reduced the growth of MDA cells without a significant effect on MCF-7 cells 
at all concentrations tested (Rowlands, Berhow et al. 2002).  
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2.7 SOYASAPONINS AND APOPTOSIS 
Both soyasapogenol A and B containing extracts have been reported to be able to induce 
apoptosis. Soyasapogenol A extract treated Hep-G2 cells induced 47 ± 3.5% of the cells to 
undergo apoptosis while soyasapogenol B extracted induced 15 ± 4.2% after 72 h treatment. 
Apoptotic fragments were confirmed by confocal laser scanning images showing evidence 
nuclear condensing (pyknosis) and fragmentation (karyorrhexis) consistent with the apoptotic 
program cell death (Chapter 3) and representative sample images is shown in Figure 4. 
Yanamandra et al. (Yanamandra, Berhow et al. 2003) demonstrated that group B soyasaponins 
had pro-apoptotic and anti-invasive activities in human glioblastoma cells (SNB 19). A well 
characterized group B extract, containing mainly soyasaponins I, II, III, and IV reduced cell 
invasion 45% compared to untreated cells measured by an in vitro invasion assay. Furthermore, 
a loss of mitochondrial trans-membrane potential was measured along with increase release of 
cytochrome C and increased caspase activity (Yanamandra, Berhow et al. 2003). Figure 5 
shows the effect of five different soyasaponin extracts on the accumulation of sub-G1 apoptotic 
cells measured by flow cytometry (Popovich and Kitts 2004; Zhang and Popovich 2008). 
Generally, soyasapogenol A containing extracted showed the greatest propensity to affect the 
cell cycle compared to soyasapogenol B containing extract tested at the LC50 concentration 
compared to a fractionated extract or a total saponin mixture.  
Extract preparation can influence the bioactive response of soyasaponins. Two different 
group B extracts were prepared, one prepared by ethanol reflux of soy flour which is rich in 
non-DDMP group B soyasaponins and one prepared by room temperature extraction 
containing an abundance of DDMP conjugated soyasaponins. The major different between the 
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two extracts was the DDMP conjugated soyasaponins βg (Zhang and Popovich 2009; Zhang, 
Yeo et al. 2009). The non DDMP soyasaponins reflux extract inhibited the proliferation of 
Hep-G2 cells to a greater extent than the room temperature DDMP soyasaponin extraction. The 
LC50 of the room temperature extract was found to be 0.9 + 0.1 mg/mL and 0.5 + 0.1 mg/mL 
for the reflux extract (Chapter 4 and 5). The reflux extract was found to induce apoptosis 
measured by the TUNEL assay and affected the cell cycle progression whereas the room 
temperature extract induced differentiation of Hep-G2 treated measured by flow cytometry 
forward side scatter (Chapter 4).  
Soyasaponins have also been reported to induce macroautophagy, which is reported to be 
a type of programmed cell death (Gessner, Riedl et al. 1993). Human colon cancer cells treated 
with soyasaponins suppressed proliferation, induced differentiation and inhibited protein 
kinase C activity (Oh and Sung 2001). Ellington et al. (Ellington, Berhow et al. 2005) reported 
that treatment of colon cancer cells (HCT-15) with an extract containing five different group B 
soyasaponins reduced cell growth after 24 and 48 h of treatment. Furthermore, treatment 
increased the percentage of cells in the S phase of the cell cycle while reducing 
cyclin-dependant kinase-2 (CDK-2) activity and a marker of macroautophagy (light chain 3) 
increased compared to non-treated cells. The induction of macroautophagy by group B 
soyasaponins was reported to be modulated by two important signaling pathway, group B 
treated cells were found to reduce Akt activity 50% affecting the phosphorylation of the 
ser
473




Figure 4. Confocal laser scanning images of propidium iodide stained hepatocarcinoma 
(Hep-G2). Cells were treated with soyasapogenol A (0.05 + 0.01 mg/mL) panel (B) and 
soyasapogenol B (0.13 + 0.01 mg/mL) panel (C) treated for 24 hours. Panel (A) represents 
untreated control cells. 
 
 
Figure 5. Flow cytometry cell cycle analysis sub-G1 accumulation of hepatocarcinoma cells 
(Hep-G2) treated with various soyasaponin extracts. Hep-G2 cells were treated for 72 hours 
the concentrations tested were as follows: SG A 0.05 + 0.01 mg/mL, SG B 0.13 + 0.01 
mg/mL, I and III (0.39 + 0.02 mg/mL), GrB Reflux 0.55 + 0.1 mg/mL, GrB 25°C (0.93 + 0.1 




2.8 SIALYTRANSFERASE ACTIVITY 
Sialytransferase activity is associated with tumor metastasis and invasion (Gessner, Riedl 
et al. 1993; Majuri, Niemela et al. 1995). Inhibiting sialytransferase activity is a useful target to 
delay the transformation of cells or slow the spread of metastasis. Wu et al. (Wu, Hus et al. 
2001) showed that soyasaponin I was a highly specific inhibitor of in vitro sialytransferase 
activity (Wu, Hus et al. 2001). Hsu et al. (Hsu, Lin et al. 2005) confirmed that soyasaponins I 
was an in vitro sialytransferease inhibitor and was found to decrease α2,3-sialylations and 
ST3Gal IV expression which are important factors of the invasive behavior of tumor cells. 
Specifically, α2,3-linked sialic acids were suggested to play a role in the potential metastasis of 
murine melanoma cancer cell line B16F10 (Chang, Yu et al. 2006). Soyasaponin I was found 
to specifically inhibit expression of α 2,3-linked sialic acids on the cell surface and to decrease 
the migration and cell adhesion to extracellular matrix proteins (Chang, Yu et al. 2006).  
Soyasaponins are a group of structurally complex bioactive molecules. The extraction, 
isolation, and purification processes are challenging and many attempts have been made to 
characterize the chemical and biological activity of soyasaponins from soy. Generally, 
soyasaponins can be extracted in native form by room temperature methanolic extraction and 
can be adequate separated and identified by HPLC-MS provided sufficient chemical standards 
or molecular weight data are available. In terms of biological activity, classification of these 
molecules suggests that soyasapogenols have greater in vitro cellular anticancer activity such 
as inducing apoptosis compared to the corresponding glycosides. However, soyasaponin 
glycosides such as soyasaponin I and III do posses biological activity and may mitigate 
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changes in cancer cell properties by inducing cellular differentiation or inhibiting enzymes 






















CHAPTER 3 TOTAL SOYASAPONINS AND CONCENTRATED 
SOYASAPOGENOL A AND B EXTRACTS EFFECTING ON HEP-G2 
CELL PROLIFERATION AND APOPTOSIS 
Preface 
Selected portions of Chapter 3 have been published in the following publication 
Zhang, W. and D. G. Popovich (2008). "Effect of soyasapogenol A and soyasapogenol B 
concentrated extracts on Hep-G2 cell proliferation and apoptosis." Journal of Agricultural 
and Food Chemistry, 56(8): 2603-2608.  
3.1 INTRODUCTION 
There has been a considerable focus on soy constituents, for their potential 
health-promoting functions such as estrogen-like activity of phytoestrogens and cholesterol 
lowering properties of soy protein. A third potential bioactive group of compounds are 
soyasaponins which are oleanane-triterpenes based on three main sapogenol (aglycones) 
structure classifications (A, B, E) and are found in various glycoside forms. Soyasaponins A 
and soyasaponins B are the most abundant type of saponins found in soybean (Glycine max 
(L.)) and related products. The saponin content is generally between 1.83%- 4.35%, 
depending on the variety and cultivation conditions (Yoshiki, Kudou et al. 1998). The 
structures of soyasapogenols A and B which has been discussed in the chapter 2 are very 
similar but differ slightly by the addition of a hydroxyl group on soyasapogenol A compared 
to soyasapogenol B (Figure 1). Soyasapogenol E is hydrolysised from the DDMP 
soyasaponins group B but the DDMP moiety is easily lost at 60 
o
C (Yang, Jin et al. 2007). 
Cytoactivity studies have reported that a concentrated total or crude soyasaponin extract can 
inhibit proliferation and induce apoptosis in Hela cells (Xiao, Huang et al. 2007; Xiao, Huang 
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et al. 2007) and induce macroautophagic cell death in cultured human colon cells (HCT-15) 
(Ellington, Berhow et al. 2005; Ellington, Berhow et al. 2006). Total soysaponins have also 
been reported to protect against tert-butyl hydroperoside damage in liver cells (Hep-G2) 
(Kinjo, Hirakawa et al. 2003)and rat hepatocytes (primary culture) (Abe, Nagafuji et al. 
2005). Soyasapogenols A and B have been shown to possess greater cytoactivity compared to 
their respective soyasaponin glycosides (Gurfinkel and Rao 2003). Rowlands et al. (2002) 
(Rowlands, Berhow et al. 2002) reported soyasapogenols A and B inhibited cell proliferation 
of estrogen insensitive breast cancer cells and soyasapogenol B inhibited estrogen sensitive 
breast cancer cells (MCF-7) while soyasapogenols A was found to be estrogenic and 
stimulated the growth of these cells. In this chapter, I have The purpose of this chapter was to 
test the hypothesis (Objectives 1, 2 and 3 in Chapter 1) that refining an extraction 
methodology (Gurfinkel, Reynolds et al. 2005) to concentrate soyapogenols derived from soy 
flour for cytoactive testing and measuring the cytoactive response varies between extracts of 
soyasaponins (TS) and ones concentrated for either soyasapogenol A (SG-A) and B (SG-B) 
on cell proliferation and apoptosis in human hepatocarcinoma cells (Hep-G2), a common 
model of carcinoma, liver metabolism and cholesterol regulation (Zhang, Qing et al. 1999). 
3.2 MATERIALS AND METHODS 
3.2.1 EXTRACTION AND ISOLATION OF SAMPLE MATERIAL 
3.2.1.1 EXTRACTION OF TOTAL SOYASAPONINS (TS) FROM SOY FLOUR 
Defatted soy flour was obtained from Archer Daniels Midland Co. (Decatur, IL, USA). 
The flour (100 g) was extracted in methanol 500 mL for 4h at 60 C as described by 
Gurfinkel et al. (Gurfinkel, Reynolds et al. 2005). After filtration, the liquid extract was 
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evaporated to 100 mL and mixed with 100 mL of 0.4 M ammonium sulphate. The mixture 
was kept at 4 C overnight. After removing the precipitate by filtration which contained 
non-soyasaponin components and protein, the liquid extraction was evaporated to less than 
100 mL in order to remove methanol and ammonia sulfate (3M) was added and refrigerated. 
The precipitate was recovered by centrifugation, lyophilized and stored at 4 C, and was 
referred herein as the total soyasaponins extract (TS). 
3.2.1.2 PREPARATION OF CONCENTRATED SOYASAPOGENOL A (SG-A) AND B 
(SG-B) EXTRACTS 
The total soyasaponin extract (560 mg) was dissolved in 200 mL methanol and 
subsequently diluted in methanol to 30% (w/o) prior to solid phase extraction (SPE). The 
sample was loaded onto a 30% methanol preconditioned 10 g C-18 Sep-Pak cartridge 
(Phenomenex, USA). The Sep-Pak was flushed with 150 mL water and then 150 mL of 30% 
methanol to remove any remaining isoflavone glucosides. The Sep-Pak was washed with 
50% methanol (100 mL) to remove the group A soyasaponins. A wash with 70% methanol 
(100 mL) removed the group B soyasaponins. The group A soyasaponins containing 50% 
methanol solution (100 mL) was diluted to 30% methanol with water (total volume 333 mL) 
and group B soyasaponins with 70% methanol was diluted to 50% for concentrating. Both 
were loaded again onto a 10 g C-18 Sep-Pak respectively and eluted by 100% methanol (each 
50 mL). 
In order to produce an concentrated soyasapogenol A and soyasapogenol B extract, 
samples were hydrolyzed using a modified method of Gurfinkel et al., (2005) (Gurfinkel, 
Reynolds et al. 2005). Briefly, group A soyasaponins were hydrolyzed in 200 mL methanol 
and 25 g anhydrous sodium sulphate and 6 mL of concentrated sulfuric acid (3% of total 
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volume) and refluxed for 5h. The methanol was decanted from the sodium sulphate and 
diluted to 30% with water and loaded onto a preconditioned 10 g C-18 Sep-Pak cartridge 
(Phenomenex, USA). The Sep-Pak was flushed with 200 mL water and then 150 mL of 30% 
methanol to remove isoflavone glucosides. Soyasapogenol A was removed by 100% 
methanol and lyophilized, yielding SG-A extract (105 mg) and a similar method yielded 
SG-B extract (112 mg). 
3.2.2 HPLC AND ESI-MS ANALYSIS 
A Waters Symmetry column (C18, 4.6 mm × 250 mm, 5 µm particle size, Waters, 
Milford, MA, USA) was used for the separation and the sample injection volume was 50 µL. 
Solvent A consisted of 0.025% (v/v) acetic acid in water, solvent B was 0.025% (v/v) acetic 
acid in acetonitrile and the column temperature was held constant at 35 C. The flow-rate was 
1.0 mL/min and the elution program was originally described by Jin M et al. (75). The 
solvent program was as listed: Time 0 (13% B), 12.5 min (30% B), 17.5 min (40% B), 23.5 
min (40% B), 27.5 min (60% B), 30.0 - 35 min (100% B), 40.0 min (13% B). The detection 
wavelength was 250 nm.  
Authentic standards of soyasapogenols A and B (APIN Chemicals LTD, UK) were used 
to establish a calibration curve. The calibration curves were linear over the amount with 
square correlation coefficients of r
2
 > 0.995. The calibration curves were y = 1×10
9
 x + 




 for soyasapogenols A and B respectively. 
Detection and molecular weight confirmation of the soyasapogenols were established by 
a Finnigan LCQ quadrupole ion trap MS with MS
n
 capabilities in negative mode with an ion 
spray voltage of 4.5 kV and with a capillary temperature of 350 C and capillary voltage of 
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40 eV, 0.4 mL/min was delivered to ESI-MS and the rest diverted to waste. The scan mass 
spectra were focused on the m/z range of 200–500 u. 
3.2.3 CELL CULTURE 
Human hepatocellular carcinoma cell line (Hep-G2) was obtained from ATCC (Manassas, 
VA). Cells were maintained in DMEM medium (Dulbecco's modified Eagle's medium, Sigma, 
Steinheim, Germany) supplemented with 10% fetal bovine serum (Sigma, Steinheim, 





Cultures were maintained at a cell concentration between 2 × 10
5
 and 1 × 10
6
 cells/mL, Cells 





Canada) every 3 days, depending on cell number and 
incubated at 37 C in a 5% CO2 humidified incubator. Viable cells and cell count were 
assessed by 0.04% trypan blue (MP Biomedicals; Ohio; USA) exclusion dye using a 
hemocytometer. Viable cell numbers were assessed in quadruplicate. 
3.2.4 CELL VIABILITY BY DOSE-RESPONSE MTT ASSAY  
A cell viability assay, based on MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide, Sigma, Steinheim, Germany) reduction by viable cells, was used in 
order to establish an LC50 (e.g. concentration to inhibit 50% of cells) of the prepared extracts. 
Hep-G2 cells were seeded in 96-well plates to a final concentration of 1 × 10
5 
cells/mL. 
Controls contained test model cells, culture medium, but no test compounds. Concentrations 
of TS extract (dissolved in medium) were between 0.1 mg/mL to 1.0 mg/mL. Concentrations 
of TG-A and TG-B extracts (dissolved in medium with less than 5% DMSO) were between 
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0.05 mg/mL to 0.5 mg/mL. Cells were incubated for 3 days before MTT was added to a 
concentration of 0.5 mg/mL and incubated in the dark for 4 h (Mosmann 1983). To solubilize 
the formazan crystal, 100 µL of SDS (10%) (National University of Medical Institution, 
Singapore) in HCl (0.1 M) was added to each well and incubated overnight. The optical 
density was read at 550 nm absorbance and 650 nm (reference absorbance) in a microplate 
reader (Multiskan Spectrum, Thermo Electron Corporation, USA). 
3.2.5 FLOW CYTOMETRY CELL CYCLE ANALYSIS 
Three distinct extracts, TS, SG-A, SG-B were added to Hep-G2 cells (1 × 10
6 
cells/mL) 
at their respective LC50 concentrations as described below. Cells were incubated at 37 C in 
a 5% CO2 humidified incubator for 24, 48, and 72 h with untreated cells acting as a control. 
After treatment, cells in suspension were centrifuged for 10 min (1000 rpm). The supernatant 
was discarded and cells were further washed twice in PBS and centrifuged to remove the cell 
pellet. The pellet was vortexed vigorously and 1 mL of ice-cold 70% ethanol was added 
slowly to fix the cells and were stored overnight at 4 C. Ethanol was removed by 
centrifugation (5 min, 3000 rpm) and gently vortexed followed by the addition of 1 mL of 
PBS containing propidium iodide (50 µg/mL) (Sigma, Steinheim, Germany) and RNase A 
(100 U/mL) (Applichem Inc, Cheshire, USA). Samples were incubated at room temperature 
for 30 min and analyzed by Dako Cytomation Cyan LX flow cytometry (Beckman Coulter, 
Fullerton, CA, USA) and software package. 
3.2.6 CONFOCAL OBSERVATION AND EXAMINATION 
Hep-G2 cells were seeded in 4-well Lab-Tek Chamber Slide System (Electron 
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Microscopy Science, Hatfield, PA) at a concentration of 2 × 10
5 
cells/mL. Three extracts TS, 
SG-A and SG-B were added to the chamber slide at their respective LC50 concentrations and 
untreated cells acted as control. Untreated and treated cells were incubated at 37 C in a 5% 
CO2 humidified incubator for 24 h. After treatment, the supernatant was discarded and cells 
were washed by PBS. Cells were treated in 4% formalin in PBS for 20 min and washed by 
PBS for 5 min. Absolute cold methanol was added to cells for 5 min to permeate the cell 
membrane. Cells were further washed in PBS and stained with 30 µg/mL propidium iodide in 
PBS and incubated for 1 hour. Cells were washed by PBS three times after incubation and air 
dried. The cell samples were scanned with confocal laser scanning microscope (CLSM) (Carl 
Zeiss Lsm510 META, Thornwood, NY). CLSM was equipped with argon laser providing 25 
mW argon ions at 458 nm, 488 nm, 515 nm and 1 mW HeNe Green 543 nm wavelengths and 
CCD camera for real color imaging by a halogen lamp or epi-fluorescence with a mercury 
lamp. The cell surface was confirmed by prescanning, and then the specimen from top to 
bottom was scanned layer by layer to obtain optical sections, and each image was recorded. 
The optical sections were reconstructed to stereoscopic images with CLSM reconstruction 
program. 
3.2.7 STATISTICAL METHODS 
A one way ANOVA (SPSS 12.0) was used to analyze the experimental data at 24, 48 and 
72 h time periods. Significance was judged at P < 0.05 using the Duncan post hoc multiple 




3.3.1 DOSE-RESPONSE LC50 DETERMINATION OF TOTAL SOYASAPONINS, 
SOYASAPOGENOL A AND B 
Dose-response curves of TS, SG-A and SG-B extracts are shown in Figures 6 and 7 
respectively. The LC50 was calculated from a plot of viability (%) versus log concentration 
(graph not shown) which yielded a linear equation of y = -132.97x + 418.96 (r
2
 = 0.9808) for 
TS and y = -66.502x + 164.01 (r
2
 = 0.9871) and y = -126.89x + 317.61 (r
2
 = 0.9238) for 
SG-A and SG-B respectively. The LC50 were determined from three separate experiments 
with at least three replicates per experiment and was found to be 0.594 + 0.021 mg/mL for TS, 
0.052 + 0.011 mg/mL for SG-A, and 0.128 + 0.005 mg/mL for SG-B. 
 
Fig 6. Dose-response relationship of a total saponin (TS) extract after 3 day incubations with 
Hep-G2 cells (n = 8, triplicate) by an MTT viability assay as outlined in the Materials and 






Fig 7. Dose-response relationship of concentrated soyasapogenol A (SG-A) and 
soyasapogenol B (SG-B) extracts after 3 day incubations with Hep-G2 cells (n = 8, 
triplicate) by an MTT viability assay as outlined in the Materials and Methods. Values are 
expressed as a percentage of untreated cells (mean + SD). 
3.3.2 HPLC-MS ANALYSIS 
Figure 8 shows the HPLC chromatogram of three extracts, a total soyasaponin extract 
and both of the concentrated soyasapogenol A and B extracts. The soyasapogenol A content 
of the SG-A extract was calculated to be 69.3 mg / 100 mg dry weight (69.3 %) and 
soyasapogenol B of the SG-B extract was found to be 46.2 mg / 100 mg dry weight (46.2%). 




Fig 8. High-performance liquid chromatographic trace of total soyasaponin and 
soyasapogenol A and B extracts (detector was PDA and wavelength was 250 nm) 
Confirmation of the soyasapogenol extracts was needed due to the similar HPLC retention 
time and this was achieved by ESI-MS analysis. Each soyasapogenol extract gives different 
EI mass spectra and exact mass measurement of the molecular ions as shown in Table 4. The 
measurement of soyasapogenols A and B [M-H]
- 
were 473.3 and 457.4 respectively 






Table 4. ESI-MS Ion Fragments of Concentrated Soyasapogenol A and B Extracts 
Soyasapogenol Empirical formula Calculated mass Main ion fragments [M-H]
-
 
A C30H50O4 474.4 473.3 
   269.3 
   249.0 
   325.2 
B C30H50O3 458.4 457.4 
   311.3 
   339.4 
   325.2 
 
3.3.3 CELL CYCLE DISTRIBUTION 
The cell cycle of the control and treated Hep-G2 cells were measured by flow cytometry 
and representative DNA histograms of Hep-G2 cells treated by test compounds at 24 hours, 













Fig 9. DNA cell-cycle histograms of control (untreated) cells and TS-, SG-A-, and 
SG-B-treated cells for 24, 48, and 72 h, respectively. Cells were fixed in 70% ethanol and 
stained with PI as described in the Materials and Methods. DNA histograms shown are 
representative histograms of three separate experiments. 
Soyasapogenol A treatment produced significantly (P < 0.05) greater sub-G1 apoptotic cells 
at 24h (25.63 + 2.1%), and 72h (47.1 + 3.5%) compared to SG-B, TS and control (Table 5). 
At 48 hours, all extracts produced significantly greater percentage of sub-G1 cells compared 
to control.  
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Table 5. Cell cycle distribution of Hep-G2 cells treated with TS, SG-A, and SG-B extracts for 
24, 48, and 72 h, and untreated cells acted as control. Values are expressed as mean + SD. 
Numbers of the same period and phase with different letters are significantly different (P < 
0.05). 























































































































3.3.4 CELL MORPHOLOGY  
CLSM images of PI stained Hep-G2 cells treated with three extracts is shown in Figure 10. 
All treated cells displayed some morphological traits such as nuclear condensing (pyknosis) 
and fragmentation (karyorrhexis) consistent with the apoptotic program cell death. 
 
Fig 10. Confocal laser scanning microscopic image after 24 h exposure to three extracts at 
their respective LC50 concentrations and stained with propidium iodide as described in the 
Materials and Methods. Panel (a) is untreated control cells, (b) represents total soyasaponins, 
and panels (c) and (d) are soyasapogenol A and B extracts, respectively 
3.4 DISCUSSION  
In this study, I have shown the relative effects of three distinct extracts derived from soy 
flour on cultured human hepatoma cells (Hep-G2) proliferation and apoptosis. Extracts that 
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contained mainly soyasapogenols A and B showed a greater ability to inhibit proliferation of 
cultured Hep-G2 when compared to a TS extract that did not contain any detectable 
soyasapogenols. These results are consistent with other reports on potential cytoactive 
saponins which show that the aglycones derived from ginseng triterpenes have a lower LC50 
than their corresponding glycosides (ginsenosides) (Popovich and Kitts 2002). The total 
soyasaponin extracted prepared from soy flour without acid hydrolysis LC50 value was 
approximately 4.5 times greater than SG-A and slightly 11 times greater SG-B extract LC50s. 
These results demonstrate that soyasapogenols have stronger affinity to inhibit cell 
proliferation than samples containing soyasaponins glycosides alone. Aglycones formed by 
hydrolysis of saponins have been reported to have biological activity which is absent or 
present in lesser degree in their corresponding saponins (Guclu-Ustundag and Mazza 2007). 
However, this is in contrast to the anti-protozoan activity of saponins glycosides in the rumen 
compared to the aglycones reviewed by Cheeke PR (2000) (Cheeke 2000). Gurfinkel DM and 
Rao AV (Gurfinkel and Rao 2003) reported a relationship between soyasaponin structure 
based on the aglycones lipophilicity and a cytotoxic effect on colon cancer cells (HT-29) 
compared to glycosidic soysaponins A1, A2, I and both deacetylated and acetylated groups. 
They reported that soysaponin III and B monoglucoronide had only marginal activity 
(Gurfinkel and Rao 2003). The non-polar relationship of ginsenosides aglycones compared to 
the glycosides have also been observed (Popovich and Kitts 2002; Popovich and Kitts 2004) 
and this influenced cytoactivity. In soy and other saponins containing plants, the saponins and 
glycosides content varies considerably and depends on plant part being extracted, plant 
species, environmental storage and processing conditions (Guclu-Ustundag and Mazza 2007) 
and can be activity influenced by in vivo intestinal biotransformation (Akao, Kida et al. 1998). 
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It is noteworthy, that all three extracts produced were able to influence sub-G1 build up of 
apoptotic cells which is a characteristic of apoptosis (Xiao, Huang et al. 2007) and SG-A 
achieved nearly 50% apoptotic cells at 72 h of exposure where as TS and SG-B did not at the 
respective LC50 concentrations. It is possible that soyasapogenol A can influence cell death 
by a different cellular mechanism compared to soyasapogenol B and a total soysaponin 
extract. Soyasaponin B has been reported to influence microautophagic cell death, a type of 
programmed cell death in cultured breast (Ellington, Berhow et al. 2005) and intestinal 
cancer cells (Ellington, Berhow et al. 2006). Saponins have long been observed to interact 
with cholesterol effectively (Cheeke 2000) and have been showed to interact and alter cellular 
membranes in cell culture models (Rao and Sung 1994). Soyasponin I, a group B 
soyasaponin, has been reported to interact with the cell surface and decease the migration and 
metastatic potential through decreasing expression of  2,3-linked sialic acid in cultured 
murine cells (Chang, Yu et al. 2006). 
  ESI-MS was used for identifying soyasapogenols A and B in this study. The HPLC and 
ESI-MS results showed the possibility to achieve completed purified soyasapogenols A and B 
but the preparative HPLC method to achieve enough amounts of completed purified 
soyasapogenols A and B still need to be optimized in the future study. It is likely that 
residences of the test samples SG-A and SG-B except for soyasapogenols were the side 
glycoside chains which dropped during hydrolysis processing and have less bioactivity.  
3.5 CONCLUSION 
In this chapter, concentrated extracts of soyasapogenols A and B extracted from soy flour 
were shown influence cultured hepatocarcinoma cell viability and apoptosis to a greater 
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degree than a soyasaponin extract. It is noteworthy that all prepared extracts of soyasaponins 



















CHAPTER 4 BIOACTIVE RESPONSES OF HEP-G2 CELLS TO 
SOYASAPONIN EXTRACTS DIFFER WITH EXTRACTION 
CONDITIONS 
Preface 
Selected portions of Chapter 4 have been published in the following publication 
Zhang, W., M. C. Yeo., F.Y. Tang and D. G. Popovich (2009). "Bioactive responses of 
Hep-G2 cells to soyasaponin extracts differs with respect to extraction conditions." Food and 
Chemical Toxicology 47(9): 2202-2208.  
4.1 INTRODUCTION 
Group B soyasaponins (oleanane triterpenoids) are amphiphilic compounds composed of 
a lipid-soluble aglycone, designated as soyasapogenol B, to which water-soluble sugar 
moieties are attached (Yoshiki et al. 1998). As presented in chapter 2, group B soyasaponins 
are the predominant soyasaponins in soy (Glycine max) (Yoshiki et al. 1998) and are 
classified into two types DDMP conjugated and non-DDMP conjugated group B 
soyasaponins. The DDMP moiety is conjugated at position 22 of the ring structure and 
includes soyasaponins βg, βa, γg and γa (Daveby et al. 1998). Non-DDMP conjugated 
soyasaponins include I, II, III and IV. Non-DDMP soyasaponins have been reported to be 
artifacts of extraction conditions and generation of Non-DDMP soyasaponins are dependent 
on solvent, temperature and storage (Hu et al. 2002).  
Crude soyasaponin extracts have been shown to be cytotoxic and are able to reduce 
cellular viability in multiple human cancer cell lines (Fournier et al. 1998; Xiao et al. 2007b; 
Xiao et al. 2007a; Zhang & Popovich 2008). Ellington et al. 2005, 2006 reported that a 
fraction of purified group B soyasaponins inhibited the proliferation of human colon 
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adenocarcinoma cells (HCT-15) at concentrations attainable from the diet. Soyasaponin I, a 
non-DDMP soyasaponin, specifically inhibited the expression of α2,3-linked sialic acids 
without affecting other glycans on the murine melanoma (B16F10) cell surface and in breast 
cancer cells (MCF-7) (Chang et al. 2006; Hsu et al. 2005). In chapter 3 of this thesis 
soyasapogenol B, the aglycone of group B soyasaponins, was shown to induce apoptosis in 
Hep-G2 cells. Gurfinkel and Rao (Gurfinkel and Rao 2003) suggested that the bioactivity of 
soyasaponins increased with increased lipophilicity and might be related to the soyasaponin 
structure.  
Thus, the aim of this chapter was to measure the bioactive response of cultured 
hepatocarcinoma cells (Hep-G2) to two types of group B soyasaponins extracts with different 
group B compositions prepared by reflux (RE) and room temperature extraction (RT) 
conditions.  
4.2 METHODS AND MATERIALS 
4.2.1 EXTRACTION METHODS  
4.2.1.1 GROUP B SOYASAPONINS EXTRACTION BY REFLUX  
The method of refluxed Group B soyasaponins (RE) has been described in the Chapter 
3 (3.2).  
4.2.1.2 EXTRACTION AT ROOM TEMPERATURE  
Defatted Soy flour (100 g) was extracted in methanol (500 mL) with stirring for 24 h at 
room temperature. After extraction, the mixture was filtered and evaporated to 100 mL and 
applied to the SPE column as described in the Chapter 3 (3.2) and is herein referred to as the 





4.2.2 HPLC AND LC-MS ANALYSIS OF TWO GROUP B SOYASAPONINS 
EXTRACTS  
A Waters (Milford, MA, USA) 2695 Separation Module with Waters 2996 Photodiode 
Array (PDA) detector HPLC system was used. The column was a Shimadzu reversed phase 
C-18, 5 μm, 250 mm x 4.6 mm internal diameter (Shimazu, Shim-pack XR-ODS, Columbia, 
MD, USA). The mobile phases were acetic acid (2%, glacial, ACS certified) (Fischer 
Scientific, Pittsburgh, PA, USA) in water (solvent A) and 100% acetonitrile (solvent B) 
(Merck, Darmstadt, Germany). The flow rate of the mobile phase was 1 mL/min with the 
column temperature was at 25
o
C and the detection wavelength was set at 210 nm. 
An external primary standard of soyasapogenol B (Apin Chemical, Oxfordshire, UK) 
with concentrations of 10 to 50μg/mL were utilized to obtain the calibration curve for the 
relative quantification of soyasaponins present in the extracts. A stock solution of 1 mg/mL of 
the standard was prepared and serial diluted. The elution gradient program of the analysis of 
the soyasaponins has been described as above.  
Samples were analyzed on a ThermoFinnigan LCQ-ESI quadrupole ion trap LC-MS 
(Thermo Fisher Scientific, Waltham, MA, USA) system with a Surveyor HPLC system 
coupled to a Finnigan AS3000 auto-sampler and using the Xcaliber 2.0 software system. The 
MS was run with the ESI probe in both the positive and negative modes. The voltage applied 
for the ionization of sample was 4.5kV. The source inlet temperature was set at 250
o
C, the 
sheath gas rate was set at 70 arbitrary units and the sweep auxiliary gas rate was set at 20 
arbitrary units (Shiraiwa et al. 1991) and a full scan mass spectrum was obtained over the 
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range of 100-1500 m/z. The mobile phases and LC program were identical to the HPLC 
analysis referred to above. 
4.2.3 CELL CULTURE  
Human hepatocarcinoma (Hep-G2) cells were used for testing the bioactivity of those 
two soyasaponins groups and the culture method has been described in the Chapter 3 (3.2.1). 
4.2.4 MTT CELL VIABILITY ASSAY 
The MTT cell viability assay was the same as the Chapter 3 (3.2.2). Cell viability (%) 
was calculated as [(mean absorbance of the sample – reference absorbance)/mean absorbance 
of the control] x 100.  
4.2.5 CELL VIACOUNT ANALYSIS 
The Guava Flow cytometer and ViaCount reagent (Guava Technologies, Inc, Hayward, 
CA, USA) were used for confirmation of the MTT viability data on cells treated with both 
group B soyasaponin extracts. Hep-G2 cells were seeded in 24-well plates to a final 
concentration of 1 × 10
5 
cells/mL. Controls contained test model cells, culture medium, but 
no test compounds. Both group B soyasaponin extracts were added at their respective MTT 
LC50 concentrations of 0.926 + 0.078 mg/mL for RT and 0.546 + 0.055 mg/mL RE (refer to 
below) for 24, 48 and 72 h. After treatment, culture medium was collected and adherent cells 
were removed by trypsin and were centrifuged for 5 min (150 g). Culture medium was 
centrifuged for 5 min (650 g) and combined with the detached cells. Cells were mixed in 2 
mL DMEM in 15 mL tubes and 50 μL of cells were mixed with 450 μL Guava ViaCount 
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reagent for 5 min in 1.5 mL microcentrifuge tubes. Guava flow cytometry system with 
CytoSoft software containing the ViaCount module was used for sample acquisition and 
analysis. 
4.2.6 CELL CYCLE ANALYSIS 
RE and RT extracts were added to Hep-G2cells (1 × 10
6 
cells/mL) at their respective 
LC50 concentrations. The cell cycle assay is similar as the Chapter 3 (3.2.3) but has some 
modifications. Cells were incubated at 37
o
C in a 5% CO2 humidified incubator for 24, 48, 
and 72 h with the untreated cells acting as a control. After treatment, floating cells in 
suspension were collected by centrifugation (10 min, 150 g). The attached cells were 
trypsinized with 2 mL trypsin for 10 min then mixed with 2 mL medium. After centrifugation 
for 10 min (650 g), the supernatant was discarded, cell pellets were combined and washed 
twice with PBS. The cell pellet was vortexed vigorously and 1 mL of ice-cold 70% ethanol 
was added slowly to fix the cells and stored overnight at 4
o
C Ethanol was removed by 
centrifugation (5 min, 650 g) and gently vortexed followed by PBS wash (twice, 1 mL). PBS 
was removed and 200 μL Guava Cell Cycle reagent was added to the cells and incubated at 
room temperature for 30 min in the dark and analyzed by Guava PCA flow cytometer with 
Cytosoft software. 
4.2.7 TUNEL APOPTOSIS OBSERVATION BY CONFOCAL MICROSCOPY 
Hep-G2 cells were seeded in 4-well Lab-Tek Chamber Slide System (Electron 
Microscopy Science, Hatfield, PA) with 1 x 10
4
cells/mL and untreated cells as controls. RE 
was added at the LC50 concentration for 72 h. After treatment, culture medium was removed 
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and cells were washed with PBS. Cells were fixed with 4% paraformaldehyde in 0.1 M 
NaH2PO4 for 15 min and washed in PBS three times for 5 min. Cells were incubated with TB 
buffer (termination buffer) 0.5% Tween-20, 0.2% bovine serum albumin (BSA) in PBS for 15 
min at room temperature. After incubation, cells were washed with PBS for 2 min. Cells were 
incubated with 50 μL of terminal deoxynucleotidyl transferase (TdT) end-labeling cocktail 
(Guava Technologies) for 1 hr at room temperature. TdT end-labeling cocktail was removed 
and the reaction stopped by immersing the cells in TB buffer for 5 min at room temperature 
then washed with PBS three times for 2 min. A blocking buffer (50μL) was added to the cells 
and incubated at room temperature for 20 min. Blocking buffer was removed by gentle 
tapping and 50 μL of avidin-FITC (fluorescein isothiocyanate) solution (Guava Technologies) 
was added to the sample cells and incubated in the dark for 30 min at room temperature. Cells 
were washed with PBS three times for 5 min in the dark and propidium iodide (PI) was added 
as a counter stain for 15 min. A cover slip was mounted with mounting gel placed under the 
cover slip and dried in the dark and viewed by Olympus Fluoview FV500 Confocal 
Microscopy (Center Valley, PA, USA). 
4.2.8 MORPHOLOGY OF RT TREATED CELLS 
RT extract was added to Hep-G2 cells (2 × 10
5 
cells/mL) which were seeded in sterile 
cell culture dishes (35 mm x 10 mm) (Corning Incorporated, Lowell, MA, USA) at LC50 
concentrations. Cells were incubated at 37 
o
C in a 5% CO2 humidified incubator for 24, 48, 
and 72 h with the untreated cells acting as a control. At each time point, cells were washed 
with PBS three times before morphology was assessed using an Olympus BX51 
(U-25ND25-2) microscope with imaging software (Center Valley, PA, USA). 
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4.2.9 STATISTICAL ANALYSIS 
A one way ANOVA (SPSS 12.0) was used to analyze the experimental data. 
Significance was judged at p < 0.05 using the Tukey post hoc multiple comparisons of 
observed means and a paired t-test with significance judge at (p < 0.05). The experimental 
procedures were as follows: HPLC and MS analysis utilized three measurements. MTT assay 
included three separate assays with three replicates, Cell ViaCount Analysis included three 
experiments with three replicates, cell cycle analysis had three experiments with three 
replicates, and confocal microscopy utilized two experiments. 
4.3 RESULTS  
4.3.1 IDENTIFICATION OF GROUP B SOYASAPONINS BY HPLC AND LC-MS 
The HPLC chromatographs of both group B soyasaponins extracts (RE and RT) are 




















Figure 11. HPLC chromatograph of the two group B soyasaponins extracts obtained from 
soy flour, under reflux (RE) and room temperature (RT) extraction conditions. 
The DDMP-conjugated group B soyasaponins, βg, αg, γg and γa, their non-DDMP 
counterparts, soyasaponins I and III, and soyasapogenol B were identified in both the RE and 
RT group B soyasaponins. The related mass spectral molecular weight is shown in Table 6.  
Table 6. LC-ESI-MS Molecular Weight Determination of Group B Soyasaponins Extracts 
Soyasaponins Observed [ M-H ]
+
 
Soyasaponin I 943.1 
Soyasaponin III 797.2 
Soyasaponin Be 941.1 
Soyasaponin βg 1069.2 
Soyasaponin βa 1039.0 
Soyasaponin γg 923.2 
Soyasaponin γa 893.2 
Soyasapogenol B 457.8 
. 
Recovery percentage of group B soyasaponins is shown in Figure 12. In the RT sample a 
significant (p < 0.05) greater amount of DDMP soyasaponin βg (46.62 ± 3.31%) was 
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measured compared to the RE sample (28.27 ± 3.11%). In the RE extract a significant (p < 
0.05) greater amount of the non-DDMP soyasaponins I (32.93 ± 2.51 %), III (14.24 ± 2.01%) 
and soyasapogenol B (2.96 ± 1.06%) were detected compared to RT (10.39 ± 0.90 %, 4.62 ± 
1.01 %, 0.28 ± 0.05 % respectively).  
 
Figure 12. The percentage of individual group B soyasaponins in reflux (RE) and room 
temperature (RT) extracts (Refer to Table 1 for mass spectral data). Bars with an asterisk (*) 
are significantly (p < 0.05) different than the corresponding pair, Tr = trace (<1%), 
Soyasapogenol B (SG-B). (The percentage reflects each individual group B soyasaponin 
weight to total group B soaysaponins weight)  
4.3.2 MTT AND VIACOUNT VIABILITY 
The dose-response curves of both RE and RT derived from the MTT assay are shown in 
Figure 13. The LC50 was calculated from a plot of viability (%) versus log concentration 
(graph not shown) which yielded a linear equation of y = -186.8x + 564.07 (r
2
 = 0.9233) for 
RT and y = -210.83x + 634.21 (r
2
 = 0.9769) for RE respectively. The LC50s were determined 
from three separate experiments with three replicates per experiment and found to be 0.926 + 
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0.08 mg/mL for RT and 0.546 + 0.06 mg/mL for RE. 
 
 
Figure 13. Dose–response relationship of the effect of reflux (RE, red line) and room 
temperature (RT, blue line) extracts after 72 h incubations with Hep-G2 cells assessed by 
MTT viability assay. Values are expressed as mean ± SD (percentage of untreated cells) of 
three separate experiments with three replicates. 
Figure 14 (a) represents the ViaCount viability results of Hep-G2 cells treated with two 
different group B soyasaponin extract at their LC50 concentrations as described above. The 
viability of RE sample was consistent with MTT assay and declined from 70.27 + 0.06% at 
24 h to 55.57 + 4.23% after 72 h. However RT treatment showed no significant difference 
compared with the control. After 72h treatment, 83.53 + 0.68% of Hep-G2 cells were found 
to have survived compared to untreated control cells of 85.47 + 1.31%. 
4.3.3 DIFFERENTIATION OF RT TREATED CELLS 
The forward side scatter (FSC) flow cytometry cell dot plots of RT and control cells 
treated for 72h and analyzed by Guava ViaCount assay are shown in Figure 14 (b). It is 
evident from the comparison with the control that the RT sample produced a different FSC 
profile compared to untreated control cells. A third population of cells was observed with a 
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lower FSC signal that was not present in the control cells.
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.   
Figure 14. Panel (a) represents the dual florocrome flow cytometry cell viability measurement using Guava ViaCount of untreated (control) and 
reflux (RE) and room temperature (RT) treated Hep-G2 cells. Panel (b) refers to representative dot plots of control and RT treatments after 72 h. 
Panel (c) refers to representative morphological observation of control and RT treated cells after 72 h. Cell viability is expressed as mean + SD, 
numbers with different letters are significantly different (p < 0.05) from each other of the same period. Figure 14 (c) shows the cellular 
morphology of 72 h RT treated and untreated control cells. Morphologically, RT treatment induced changes in the shape, size as well as growth 
pattern. RT treated cells segregated and formed small clusters or individual cells. The size of RT treated cells appeared larger than control cells 
(untreated Hep-G2 cells) which grew into colonies and further into a mono-layer. 
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4.3.4 SUB-G1 CELL CYCLE AND TUNNEL ANALYSIS 
Representative DNA cell cycle histograms of the control and treated Hep-G2 cells 
treated at 24 -72 h are shown in Figure 15.  
 
Figure 15. DNA cell-cycle histograms of untreated (control) cells, reflux (RE) and room 
temperature (RT) extracts treated cells for 24, 48 and 72 h. Cells were fixed in 70% ethanol 
and stained with PI as described in the Materials and Methods. DNA histograms shown are 
representative histograms of three separate experiments. 
 
RE treatment produced significantly (p < 0.05) greater Sub-G1 apoptotic cells at 24 h 
(9.80 + 0.35%), 48 h (9.70 + 0.26%) and 72 h (3.27 + 0.38%) compared to RT and control 
(Table 7). RT treatment did not produce any significant difference in sub-G1 cells percentage 
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compared to control.  
Table 7. Sub-G1 accumulation of Hep-G2 cells treated with RE and RT extracts for 24, 48 
and 72 h 
Sub-G1 Apoptotic Population (%) 























Confocal laser scanning images of PI and FITC counter stained Hep-G2 cells treated 
with RE extracts is shown in Figure 16. The apoptotic fragments were stained green, clearly 
distinguishing them from the untreated control cells.  
 
Fig 16. TUNEL Apoptosis Determination of Group B Soyasaponins (Reflux) treatment with 
count staining by PI (red) and FITC (green) and scanned by Confocal Microscopy (The 




In this chapter, two types of group B soyasaponins extracts were obtained from defatted 
soy flour. The main difference in the composition of group B soyasaponins of the room 
temperature (RT) compared to reflux extraction (RE) was the amount of DDMP soyasaponins. 
DDMP soyasaponins were greater in RT extract compared to RE. This is consistent with 
results reported in the literature (Hu et al. 2002; Kudou et al. 1993) that DDMP soyasaponins 
are heat labile and can be easily converted to their non-DDMP counterparts such as 
soyasaponin I. A greater amount of non-DDMP group B soyasaponins and their aglycone 
soyasapogenol B were found in the RE extracts compared to RT extracts.  
The results presented herein suggests that both RE and RT group B soyasaponins 
extracts have inhibitory effects on the growth of cultured human hepatocarcinoma Hep-G2 
cells assess by the MTT viability assay, an indicator of cellular redox activity (Bernas & 
Dobrucki 2002). RE extract exhibited a greater cytotoxicity compared to RT extract was 
determined to have 0.42 mg/mL lower LC50 compared to the RT. RT MTT dose-response 
curve was near linear until 0.7 mg/mL compared to 0.3 mg/mL for RE. The Guava ViaCount 
viability assay which could distinguish between viable and non-viable cells based on the 
differential permeability of two DNA flourochorme binding dyes confirmed the LC50 value 
of the MTT assay for the RE resulting in 55.57 + 4.23% viability after 72 h. This was just 
5.6% above the MTT LC50. Unexpectedly RT viability measured by the ViaCount viability 
assay was not similar to the MTT LC50. The RT ViaCount viability after 72 h treatment was 
similar to control cells. One possible explanation for this difference is that RT extracts 
induced Hep-G2 cancer cells to differentiate and reduced or changed the cellular metabolic 
activity resulting in a higher than expected MTT LC50 calculation, This hypothesis is 
supported by both morphological and flow cytometer evidence of a cellular change. Flow 
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cytometer analysis using forward side scatter (FSC) cell scatter plots showed RT treatment 
induced changes in the cell FSC properties and produced a third population of cells with a 
lower FSC signal not present in the control samples. Differences in FSC properties are 
consistent with heterogeneous culture cells and differentiation (Yamamoto et al. 2008). 
Morphologically, RT induced changes in the shape as well as growth pattern of Hep-G2 cells. 
RT treated cells grew slower, rounder, larger and not in the typical colonies associated with 
Hep-G2. This change in growth characteristic can lead to a potential underestimation of the 
LC50 MTT viability data. Hep-G2 cells have been reported to be induced to differentiate by 
treatment with 10-hydroxycamptothecin (HCPT), a Camptotheca alkaloid with reported 
antitumor activity (Zhang, Jiang et al. 2000; Leu, Chen et al. 2008). The inhibition of DNA 
topoisomerase I (Topo I) has also been reported as a trigger for the drug-induced 
differentiation in Hep-G2 cells (Zhang, Jiang et al. 2000). In the RT extract, nearly 50% of 
the soyasaponin content is DDMP-soyasaponins βg, which could be converted to 
soyasaponin I during metabolism (Hu et al. 2002). Hsu (Hsu, Lin et al. 2005) reported that 
soyasaponin I was cell-permeable in breast cancer cells (MCF-7) and could selectively inhibit 
the cellular α2,3-sialyltranserase activity, possibly modifying adhesion and tumor metastases 
properties. In addition, soyasaponin I modulated the cell surface sialylation, which is 
involved in cellular transformation to malignant cells (Warren, Buck et al. 1972; Pilatte, 
Bignon et al. 1993), without directly inhibiting cell growth or interfering with proportion of 
cell cycle (Hsu et al. 2005). 
It is noteworthy, that only RE treatment was able to influence the accumulation of 
sub-G1 apoptotic cells and confirmed morphologically by the Tunnel assay. The RE extract 
yielded significantly (p < 0.05) larger amounts of structural related soyasaponin I, III and the 
aglycone soyasapogenol B compared to RT extract. In the Chapter 3, soyasapogenol B was 
found to induce apoptosis in Hep-G2 cells. Gurfinkel & Rao 2003 reported that 
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soyasapogenol A and B completely suppressed the growth of colon cancer cells (HT-29). 
The structure of soyasaponins is likely to be a very important factor in determining their 
bioactivities. Lipophilic soyasapogenins are more bioactive than the glycosidic soyasaponins 
counterparts (Gurfinkel et al. 2005). The reduced activity of the glycosides may reflect the 
reduced efficiency to penetrate the lipophilic cell membrane (Pilatte et al. 1993; Warren et al. 
1972). DDMP-soyasaponins such as soyasaponins βg and βa with sugar moieties attached at 
position C-3 and DDMP conjuation at postion C-22 of the triterpene ring structure are the 
major components in our RT extracts. It is possible that the presence of the sugar moieties 
and DDMP moiety could interfere with the binding of soyasaponins to possible cellular 
receptors, even if they were able to penetrate the cell membrane (Gurfinkel & Rao 2003). 
4.5 CONCLUSIONS 
To my knowledge, this is the first report of two extraction techniques yielding different 
bioactive effects on Hep-G2 cells. A reflux extraction consisting of group B soyasaponins 
extract was found to be more cytotoxic which yielded a lower LC50, and induced apoptosis 
to a greater extent than a room temperature extraction. However a room temperature extract 
contained greater amounts of DDMP conjugated soyasaponins, which may have an effect on 
the cellular morphology and increase the propensity to induce cellular differentiation in 








CHAPTER 5 GROUP B OLEANANE TRITERPENOID EXTRACT 
CONTAINING SOYASAPONINS I AND III FROM SOY FLOUR 
INDUCES APOPTOSIS IN HEP-G2 CELLS 
Preface 
Selected portions of Chapter 5 have been published in the following publication 
Zhang, W. and D. G. Popovich (2010). "Soyasaponins I and III derived from soy flour induce 
apoptosis in Hep-G2 cells." Journal of Agricultural and Food Chemistry, 
doi:10.1021/jf9037979 
5.1 INTRODUCTION 
Group B soyasaponins are the most abundant group of oleanane triterpenoids (Shiraiwa, 
Harada et al. 1991) found in soy and are thought to contribute to soy’s chemopreventative 
properties (Rao and Sung 1994). Soyasaponin I and structurally related compound 
soyasaponin III are monodesmodic triterpenoids. Soyasaponin I structure has an additional 
rhamnose moiety compared to soyasaponin III. In plants saponins are secondary metabolites 
whose function is likely to thwart or discourage herbivore predators but like many secondary 
plant metabolites there has been a resurgence interest into the associated bioactivity of these 
molecules (Wink 2008). Much of the bioactive research on soyasaponins has utilized crude 
methanolic extracts from soy flour (Zhang and Popovich 2008; Zhang, Teng et al. 2009). 
There are a few reports relating to the suppression of cultured cancer cell growth by the 
aglycones soyasapogenols A and B (Gurfinkel and Rao 2003; Zhang and Popovich 2008). I 
have reported in chapter 4 that the bioactivity of soyasaponins extracts depends on group B 
soyasaponin composition which varied by extractions conditions. There are only a few 
reports in the literature relating the bioactivity to specific soyasaponins. This is likely due to 
the complex and diverse chemical structures rendering purification difficult and laborious. 
Specific soyasaponins such as soyasaponin I have been reported to interact with sialic acid on 
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the cellular surface of culture melanoma cells (B16F10) cells potentially reducing metastatic 
ability of cancer cells (Hsu, Lin et al. 2005; Chang, Yu et al. 2006). 
Soyasaponins are found in low amounts in soy and are usually extracted together with 
isoflavones due to the overlapping polarity of the compounds making specific determinates of 
groups or individual soyasaponins’ bioactivity difficult (Zhang, Teng et al. 2009). A method 
has been developed to separate group B soyasaponins from group A, remove the competing 
isoflavones and have produced an extract that containing 62% soyasaponin I and 29% 
soyasaponin III by alkaline hydrolysis (Chapter 4). However the bioactivity has not been 
established. The objectives of this current study was to determine the bioactivity of a purified 
soyasaponin extract that contains mainly soyasaponin I and III on hepatocarcinoma (Hep-G2) 
cell growth, cell cycle analysis and two different specific measures of apoptosis.  
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5.2 METHODS AND MATERIALS 
5.2.1 BASIC HYDROLYSIS FOR YIELDING SOYASAPONINS I AND III 
The preparation and analysis of an extract containing group B soyasaponins I (62 ± 
0.9%) and III (29 ± 2.9%), soyasaponins g (3.2 ± 0.2%) and Be (2.6 ± 0.5%) extracted from 
defatted soy flour and the detail extraction method will be described in the Chapter 6 (Zhang, 
Teng et al. 2009). Briefly, 100g defatted soy flour was obtained from Archer Daniels Midland 
Co. (Decatur, IL, USA) and was extracted in methanol (500 mL) with stirring for 24 h at 
room temperature, filtered and vacuum evaporated. A 10 g C-18 Sep-Pak (Phenomenex, 
Torrance, CA, USA) cartridge was conditioned with water and the soyasaponin sample was 
applied. The cartridge was washed with water (150 mL) to remove any traces of 
carbohydrates and washed using 45% methanol (200 mL) to remove any isoflavones 
(Gurfinkel, Reynolds et al. 2005) and group A soyasaponins were removed with a 50% 
methanol wash. Group B soyasaponins were eluted with methanol (80%). Group B 
soyasaponins in 80% methanol were diluted to 50% and reapplied to the SPE column and 
eluted with 50 mL of absolute methanol. Sodium hydroxide (5% (v/v)) was added to group B 
soyasaponins and mixture was hydrolyzed for 30 min at temperature of 80
o
C in sealed tubes. 
After hydrolysis, the solution was diluted with water until the concentration of methanol was 
50% and applied to Phenomenex 10 g C-18 Sep-Pak cartridge which was pre-conditioned 
with deionised water. The cartridge was washed with water (200 mL) and the hydrolyzed 
solution was eluted with methanol. 
5.2.2 CELL CULTURE AND MTT VIABILITY 
Hep-G2 cells culture and MTT assay methods were the same as previous chapters 
described. 
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5.2.3 CELL CYCLE ANALYSIS 
Soyasaponin I and III extract was added to Hep-G2 cells (1×10
6 
cells/mL) at the LC50 
concentration (0.389 + 0.02 mg/mL described below). The cell cycle assay method was the 
same as previously described in the Chapter 4 (4.2.3). 
5.2.4 TUNEL APOPTOSIS ASSAY 
Hep-G2 cells were seeded in 24 well plates at a concentration of 1 × 10
5
 cells/mL for the 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Soyasaponin I and III 
extract was added at the LC50 concentration for 72 hours, untreated cells acted as a control. 
After treatment, culture medium was removed and placed in a 15 mL conical screw cap tubes. 
Cells were washed with PBS and detached with trypsin (described above) and combined with 
the media in the conical tubes. The mixture was centrifuged (300 g, 7 min) to remove the 
supernatant and the cells were fixed in methanol (70%) for 12 hours. Methanol was removed 
by centrifugation (300 g, 7 min) and cells were washed three times with 1 mL of the wash 
buffer (Guava Technologies) according to manufacturer’s protocol. Cells were stained with 
the rinsing buffer and suspended in 50 μL of the anti-BrdU Staining mix (Guava technologies) 
for 30 min at room temperature in the dark. At the end of incubation, 150 μL of rinsing buffer 
was added to each tube and analyzed using a Guava PCA system flow cytometer.  
5.2.5 CASPASE APOPTOTIC ASSAY 
The extract was added at the LC50 concentration to 1 × 10
6
 cells/mL in 24 well plates. 
After 48 hour treatment, medium was removed and centrifuged (350 g for 5 min). Cells were 
detached by typsinization, washed with PBS twice and combined with the collected medium 
and cell concentration adjusted to 5 × 10
5
 cells/mL using 1 X Apoptotic Wash Buffer (Guava 
Technology). Sulforhodamine-valyl-alanyl-fluoromethyl-ketone (20X SR-VAD-FMK) 
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reagent was added according to manufacturer’s instructions and incubated for 1 hour at 37oC 
in the dark. Cells were washed twice in washing buffer and re-suspended in 1X apoptotic 
wash buffer (100 μL) and 5μL of caspase 7-AAD regent (Guava Technologies) was added 
and incubated for 10 min at room temperature. After incubation, the sample volume was 
adjusted to 200 μL with 1X Apoptosis Wash Buffer and analyzed on a Guava PCA flow 
cytometer.  
5.2.6 CELL MORPHOLOGY 
Hep-G2 cells were seeded in 4-wells Lab-Tek Chamber Slide System (Electron 
Microscopy Science, Hatfield, PA, USA) with 1 × 10
4
 cells/mL and untreated cells as 
controls. The extract was added at the LC50 concentration for 72 h. After treatment, culture 
medium was removed and cells were washed with PBS. Cells were fixed with 4% 
paraformaldehyde in 0.1M NaH2PO4 for 15 min and washed in PBS three times for 5 min. 
Cells were incubated with termination buffer (TB, 0.5% Tween-20, 0.2% bovine serum 
albumin (BSA) in PBS) for 15 min at room temperature. After incubation, cells were washed 
with PBS for 2 min and incubated with 50 μL of terminal deoxynucleotidyl transferase (TdT) 
end-labeling cocktail (Guava Technologies) for 60 min at room temperature. TdT 
end-labeling cocktail was removed and the reaction stopped by immersing the cells in TB 
buffer (1X) for 5 min at room temperature then washed with PBS three times for 2 min. A 
blocking buffer (50 μL) was added to the cells and incubated at room temperature for 20 min. 
Blocking buffer was removed by gentle tapping, 50 μL of avidin-FITC solution (Guava 
Technologies) was added to the sample cells and incubated in the dark for 30 min at room 
temperature. Cells were washed with PBS three times for 5 min in the dark and propidium 
iodide (PI) was added as a counter stain cells for 15 min. A coverslip was mounted and cell 
imaged was acquired by Olympus Fluoview FV500 Confocal Microscopy (Center Valley, PA, 
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USA). 
5.2.7 STATISTICAL METHODS 
A one way ANOVA (SPSS 12.0) was used to analyze the experimental data. 
Significance was judged at p < 0.05 using the Tukey post hoc multiple comparisons of 
observed means and a students paired t-test with significance also judged at p < 0.05. The 
MTT, caspase and TUNEL assays were preformed with 3 replicates in 3 separate experiments. 
TUNEL confocal image acquisition consisted of 2 replicates with 2 separate experiments.  
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5.3 RESULTS 
5.3.1 MTT CELL VIABILITY AND CELL CYCLE ANALYSIS 
The MTT cell viability dose-response relationship of soyasaponin I and III extract effect 
on Hep-G2 cell growth is shown in Figure 17. The LC50 was calculated from a plot of 
viability (%) versus log concentration (graph not shown) which yielded a linear equation of y 
= -229.8x + 645.31 (R
2
 = 0.9781). The LC50 was determined from three separate 
experiments with three replicates per experiment and was found to be 0.389 + 0.02 mg/mL.  
  
Fig 17. MTT dose–response relationship viability curve of soyasaponin I and III extract after 
72 h treatment of Hep-G2 cells. Values are expressed as mean ± SD and expressed as a 
percentage of untreated cells control. Experiments consisted of eight replicates repeated in 
three separate experiments. 
 
Representative DNA cell cycle histograms of untreated control and soyasaponin I and III 
extract treated Hep-G2 cells for 24, 48 and 72 h are shown in Figure 18a and the 
corresponding cell cycle data of each phase of the cell cycle is shown in Figure 18b.  
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Fig 18. Representative cell cycle histograms and corresponding table of analysis. Asterisk 
(*) denotes a significant difference (p < 0.05) compared to corresponding control value at 
specific time. 
 
Soyasaponin I and III extract produced significantly (p < 0.05) greater percentage of cells in 
G1 phase compared to untreated control cells after 72 h of treatment and significantly (p < 
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0.05) decreased in S-phase cells after 24 h and cells in G2/M phase after 48 and 72 hours of 
treatment. Sub-G1 apoptotic cells were significantly (p < 0.05) increased after 24 h (5.50 + 
0.56%), 48 h (17.67 + 0.42%) and 72 h (8.90 + 0.50%) compared to control cells 24h (0.43 + 
0.21%), 48h (0.73 + 0.12%) and 72h (0.80 + 0.17%) respectively. The maximum sub-G1 
accumulation was observed at 48 h hours of treatment.  
5.3.2 CASPASE APOPTOSIS ASSAY 
Figure 19 shows the different stages of apoptosis in Hep-G2 cells treated with soyasaponin I 
and III extract measured by utilizing caspase antibodies and dual fluorescent labeled cells 
assessed flow cytometry analysis. Quadrant analysis effectively shows cells that are alive 
(bottom left quadrant), dead (top left quadrant), are undergoing mid (bottom right quadrant) 




Fig 19. Representative flow cytometer analysis of casaspase activity after Soyasaponins I and 
III extract treatment. Hep-G2 cells were treated by Soyasaponins I and III extract at LC50 
concentration determined the MTT analysis for 48 hours. Untreated cells acted as controls. 
Data are expressed as mean ± SD, asterisk (*) represents a significant different (p < 0.05) 
compared to corresponding control value.  
 
After 48 h treatment, soyasaponin I and III extract treated cells showed a significant (p < 
0.05) reduction in the percentage of viable cells which corresponded to a reduction of 31.2 % 
compared to control cells. Cells undergoing mid-apoptotic events showed a significant (p < 
0.05) increase for treated cells compared to a control (6.89%) and a significant (p < 0.05) 
increase (12.47 %) for cells in late apoptotic stage. Dead cells were also significantly (p < 
0.05) increased compared to control (11.82%). 
5.3.3 TUNEL APOPTOSIS AND CONFOCAL LASER SCANNING MORPHOLOGY 
Figure 20 shows the results of the TUNEL assay assessed using flow cytometry. The 
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analysis showed a large significant (p < 0.05) increase in apoptotic cells after soyasaponin I 
and III extract treatment and a corresponding decrease in non-apoptotic cells compared to 
untreated control cells.  
 
Fig 20. TUNEL apoptotic analysis of Soyasaponins I and III extract treated Hep-G2 cells for 
72 h at the LC50 concentration. Data are expressed as mean ± SD, asterisk (*) represents a 
significant different (p < 0.05) compared to corresponding control value.  
 
This increase in apoptotic cells was confirmed by confocal laser scanning microscopy 
TUNEL images of the treated cells (Figure 21). Cell fragments that are stained green (FITC) 
are positive for apoptosis events which is not visible for the untreated control cells.  
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Fig 21. TUNEL apoptosis confocal laser scanning representative image of Hep-G2 cells 
treated with soyasaponins I and III extract at the LC50 concentration for 72 h. Cells were 
stained by both PI (red) and FITC (green). Control cells (left panel) are untreated cells and 
show no evidence of apoptosis compared to soyasaponin I and III extract treated cells (right 
panel) that show evidence of apoptotic fragments (green, FITC stain) (The detail of FITC 




5.4 DISCUSSION  
An oleanane triterpene soyasaponin extract derived from soy four containing primarily 
group B soyasaponins I and III reduced the growth of Hep-G2 cells in a dose dependent 
manner measured by the MTT viability assay. Saponins from a variety of plants have been 
reported to reduce the growth of cancer cells. Dammarane triterpenoids from ginseng (Panax 
quinquefolius), and oleanane triterpene from licorice root (Glycyrrhiza uralensis) reduced a 
culture cancer cell growth to different degrees (Popovich, Yeo et al. 2009). Triterpenes in 
general seem to have a characteristic effect on cultured cell growth that is dependant on 
structural characteristics (Popovich and Kitts 2002; Gurfinkel and Rao 2003; Popovich and 
Kitts 2004; Zhang and Popovich 2008). Monodesmodic saponins, having one attachment site 
of sugar glycoside have been reported to be more biologically active compared to the 
bidesmodic saponins, possessing two sugar attachment sites and bidesmodic forms may be 
the storage forms in the plants (Wink 2008). Specifically, soyasaponin bioactivity has largely 
been studied using crude extracts or semi purified fractions. Little is known about the 
bioactivities of specific compounds or structurally related groups of compounds such as the 
monodesmodic soyasaponins I and III. The aglycones of the two main groups of 
soyasaponins, group A and group B, have been reported to induce apoptosis in cultured 
Hep-G2 (Chapter 3) and fractioned soyasaponins extract induced apoptosis in Hela cells 
(Xiao, Huang et al. 2007). Concentrated group B soyasaponin extracts prepared by reflux 
containing mainly soyasaponins I, III and the group B aglycone reportedly increased 
apoptotic cells while an extract containing and abundance of 
2,3-dihydro-2,5-dihydroxy-6-methyl-4H-pyran-4-one (DDMP) conjugated soyasaponin βg 
induced cellular differentiation in Hep-G2 cells (Chapter 4). A group B soyasaponin extract 
was reported to induce programmed microautophagic cell death in colon cancer cells 
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(HCT-15) (Ellington, Berhow et al. 2005). The results contain herein suggest that group B 
soyasaponin extract that contained a majority structurally related soyasaponins I and III 
induce apoptosis in cultured Hep-G2 cells. This is evident by the use of three distinct assays 
used to measure apoptosis. The accumulation of sub-G1 cells measured during cell cycle 
analysis suggest apoptotic cells death, while the caspase and TUNEL measurement confirm 
apoptotic cell death. Using the TUNEL assay which is specific for apoptotic fragments 
showed that nearly 41% of the cells were positive for apoptosis after 72 h of treatment at the 
LC50 concentration. This indicates that a majority of treated cells were apoptotic. The dual 
labeled multicaspase assay was positive for apoptosis indicated the caspase serine proteases 
were expressed after treatment and likely triggered cell death via apoptosis. Specific studies 
are needed to determine the precise caspase that was activated. Soyasaponin I has been 
reported to interact with sialic acid on the surface cultured melanoma cells and breast cancer 
cells possibly reducing the metastatic potential of cancer cells (Hsu, Lin et al. 2005; Chang, 
Yu et al. 2006). Monodesmodic saponins in generally may interact with membrane function 
(Popovich and Kitts 2002; Popovich and Kitts 2004), possibly through an association with 
cholesterol (Wink 2008)).  
5.5 CONCLUSION 
Specific mechanistic studies are needed to definitely assess these effects; however, the 
final outcome for cultured cancer cells, shown in this chapter, is apoptotic cell death. This is 
important finding as it lends credence to the multi facet nature of soyasaponin as potential 
chemopreventative agents. In the next chapter, I will introduce the generation process of 




CHAPTER 6 THE EFFECT OF EXTRACTION, PURIFICATION AND 
HYDROLYSIS ON THE GENERATION OF GROUP B SOYASAPONINS 
I AND III 
Preface 
Selected portions of Chapter 6 have been published in the following publication 
Zhang, W., S. P. Teng and D. G. Popovich. (2009). "Generation of Group B Soyasaponins I 
and III by Hydrolysis." Journal of Agricultural and Food Chemistry 57(9): 3620-3625.  
6.1 INTRODUCTION 
Soyasaponins have generated a great deal of attention due to their potential 
health-promoting functions, particularly related to the chemopreventative (Rao and Sung 
1994; Fournier, Erdman et al. 1998) and cholesterol lowering properties (Oakenfull and 
Sidhu 1990). Furthermore, specific soyasaponins have been reported to possess bioactive 
properties in cell culture studies in previous chapters (Hsu, Lin et al. 2005; Chang, Yu et al. 
2006; Zhang and Popovich 2008). Soyasaponin from lentils and chickpeas have been 
reported to be partially degraded into Soyasaponin I during cooking (Ruiz, Price et al. 1996). 
Soyasaponin βg is likely heat labile and was found to significantly decreased when heated at 
65
o
C, while the corresponding concentration of non-DDMP soyasaponin I increased 
proportionally (Hu, Lee et al. 2002). When the alcoholic extract of soy hypocotyls was heated 
at 80
o
C for 5 h, Kudou (Kudou, Tonomura et al. 1993) observed that soyasaponins αg
 and βg
 
converted into soyasaponins V and I respectively. Soyasaponin βg has been reported to be 
stable at acidic pH but rapidly degraded into soyasaponin I at basic pH or in the presence of 
ferric chloride (FeCl3) (Okubo 1996). These reports suggest that to produce specific 
soyasaponins either DDMP or non DDMP counterparts require specific control of extraction 
pH, temperature and solvent. Non-DDMP group B soyasaponins such as soyasaponin I have 
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been reported to be bioactive for human health (Ellington, Berhow et al. 2005; Chang, Yu et 
al. 2006). However, group B soyasaponins chemistry and bioactivity have not been fully 
characterized due to the complex structure and artifacts (Ireland and Dziedzic 1986) and 
labor intensive purification and isolation of these compounds. 
The aim of this chapter is to compare extraction conditions for removing interfering 
isoflavones from soyasaponins found in soy flour using a variety of extraction techniques, 
solid phase extraction (SPE), high performance liquid chromatography (HPLC) and mass 
spectrometry (MS) and acid and base hydrolysis to determine which conditions are optimal 
for obtaining and extracting primarily containing soyasaponins I and III from soy flour. 
6.2 MATERIALS AND METHODS 
6.2.1 EXTRACTION METHODS COMPARISON 
6.2.1.1 EXTRACTION BY REFLUXING  
Defatted soy flour (10 g) was obtained from Archer Daniels Midland Co. (Decatur, IL, 
USA) and refluxed in methanol (50 mL) for 4 hours at 60
o
C (Gurfinkel, Reynolds et al. 2005). 
After refluxing, the mixture was filtered and the methanol extract was evaporated to 10 mL. 
An aliquot (250 μL) was collected and passed through 0.45 μm pore size nylon membrane 
filter (Millipore) before diluting with methanol to 2 mL for chromatographic analysis. 
6.2.1.2 EXTRACTION BY ULTRASOUND  
Ultrasonic extraction was carried out in Elma D-78224 S60H sonicator with frequency 
of 50 Hz and mean power of 550W. Soy flour (10 g) was ultrasonically extracted in methanol 
(50 mL) twice, each time for 2 hours (Jin, Yang et al. 2006). After extraction, the mixture was 
filtered and the methanol extract was evaporated to 10 mL. An aliquot (250 μL) was collected 
as described above. 
6.2.1.3 EXTRACTION BY SOXHLET 
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Soxhlet extraction was carried out in an automatic 2050 Soxtec Soxhlet extractor with a 
2050 Soxtec Avanti Extract unit, 2050 Soxtec Avanti Control unit and 2050 Avanti Drive unit. 
Soy flour (10 g) was heated in methanol for 1.5 hour under the boiling state before beginning 
the Soxhlet extraction (4 hours). After extraction, the methanol extract was evaporated to 10 
mL in a volumetric flask and an aliquot (250 μL) was collected as described above. 
6.2.1.4 EXTRACTION AT ROOM TEMPERATURE  
Soy flour (10 g) was extracted in methanol (50 mL) with stirring for 24 hours and 48 
hours at room temperature. After extraction, the mixture was filtered and evaporated to 10 
mL and a 250μl of the aliquot as described above. 
6.2.1.5 HPLC ANALYSIS OF SOYASAPONINS AND SOY ISOFLAVONES  
A Waters (Milford, MA, USA) 2695 Separation Module with Waters 2996 Photodiode 
Array (PDA) detector HPLC system was used. The column used was a Shimadzu reversed 
phase C-18, 5μm, 250 mm x 4.6 mm internal diameter (Shimazu, Shim-pack XR-ODS, 
United States). The mobile phases were 0.025% acetic acid (glacial, ACS certified) (Fischer 
Scientific, Pittsburgh, USA) in water (solvent A) and 0.025% acetic acid in acetonitrile 
(solvent B) (Merck, Darmstadt, Germany). The flow rate of the mobile phase is 1mL/min 
with the column temperature set at 25
o
C. Detection wavelength was set at 210nm. 
In addition, external primary standard soyasapogenol B (APINS Chemical Ltd, USA) 
concentrations of 10 to 50μg/mL were utilized to obtain the calibration curve for the 
quantification of total soyasaponins present in the extracts. A stock solution of 1000 μg/mL of 
the standard was prepared and serial diluted. The elution gradient program of the analysis of 
total soyasaponins has been described in the Chapter 3 (3.2). For analysis of soy isoflavones, 
HPLC method was the same as described above. 
6.2.1.6 LC/MS ANALYSIS OF TOTAL SOYASAPONINS AND SOY ISOFLAVONES  
Samples were analyzed on a ThermoFinnigan LCQ-ESI quadrapole ion trap LC-MS 
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system with a Surveyor HPLC system coupled to a Finnigan AS3000 auto-sampler and using 
the Xcaliber 2.0 software system. The MS was run with the ESI probe in both the positive 
and negative modes. The column used was a Waters reversed phase C-18, 5μm, 250 mm x 4.6 
mm internal diameter. The voltage applied for the ionization of sample was 4.5kV. The source 
inlet temperature was set at 250
o
C, the sheath gas rate was set at 70 arbitrary units and the 
sweep auxiliary gas rate was set at 20 arbitrary units (Shiraiwa, Harada et al. 1991) and a full 
scan mass spectrum was obtained over the range of 100-1500 m/z. The mobile phases and LC 
program was identical to the HPLC analysis and is described above. 
6.2.2 COMPARISON OF SOYASAPONIN CONCENTRATION METHODS 
6.2.2.1 TOTAL SOYASAPONINS EXTRACTION 
Soy flour was extracted in methanol for 24 h at room temperature as described above 
and further subjected to three concentration methods described below. HPLC and LC/MS 
analysis is also described above. 
6.2.2.2 BUTANOL LIQUID-LIQUID EXTRACTION 
Each 100 mL of aliquot of the total soyasaponins in methanol was evaporated to dryness 
under reduced pressure and dispersed in butanol (Merck, Darmstadt, Germany)-water 
(Millipore) layer in a ratio of 1:1 by volume. The mixture was shaken and allowed to stand 
overnight. The butanol organic layer was collected and evaporated to dryness under reduced 
pressure before dispersing in methanol (Shiraiwa, Harada et al. 1991). 
6.2.2.3 AMMONIUM SULPHATE AS THE EXTRACTOR 
Each 100 mL of aliquot of total soyasaponins was mixed in a ratio of 1:1 with 0.4M of 
ammonium sulphate (Sigma, United States) and allowed to stand overnight at 4
o
C (Gurfinkel, 
Reynolds et al. 2005). The mixture was then centrifuged at 450g for 5 min at 4
o
C to remove 
any precipitate which contained soy proteins. The supernatant was then evaporated to 50% of 
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its volume to remove any methanol present in the sample and the total volume of the sample 
was made up to 200 mL with deionised water. Ammonium sulphate was added to bring the 
solution to a concentration of 3M. The solution was then allowed to stand overnight at 4
o
C. 
The precipitate which formed, containing the soyasaponins, was collected by centrifuging the 
mixture at 450g for 5 min at 4
o
C. The residue was then dissolved in methanol and centrifuged 
as described above to remove the precipitate which contained the ammonium sulphate.  
6.2.2.4 SOLID PHASE EXTRACTION (SPE) 
Each 100 mL of aliquot of the total soy extract in methanol was diluted with water to a 
concentration of 40% methanol. A 10 g C18 Sep-Pak (Phenomenex, Torrance, CA,USA) 
cartridge was first washed with methanol before conditioning with water and the samples 
were applied. The cartridge was washed with water (150 mL) to remove any traces of 
carbohydrates and washed using 45% methanol (200 mL) to remove any isoflavones 
(Gurfinkel, Reynolds et al. 2005). Soyasaponins were eluted by 70% methanol. Soyasaponins 
(70% methanol) were diluted to 30% methanol and reloaded on SPE column. Absolute 
methanol was used to elute total soyasaponins. 
6.2.3 COMPARISON OF HYDROLYSIS CONDITIONS TO GENERATE 
SOYASAPONIN I AND III 
6.2.3.1 PREPARATION OF GROUP B SOYASAPONINS 
The preparation method of group B soyasaponins has been described in the Chapter 3 
but with some modification. Total soyasaponins from 100 g soy flour obtained from room 
temperature extraction with SPE concentration as described above. Samples were loaded onto 
an SPE column as described above and the isoflavones were removed with methanol (45%) 
and group A soyasaponins were removed with a 50% methanol wash. To elute Group B 
soyasaponins, 100 mL of 80% methanol was used. The cartridge was then washed with 
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absolute methanol to remove any non-polar compound. Group B soyasaponins in 80% 
methanol were diluted to 50% and reloaded to SPE column, then eluted by 50 mL 100% 
methanol. 
6.2.3.2 ACID HYDROLYSIS IN AQUEOUS AND ANHYDROUS MEOH  
Concentrated hydrochloric acid (5% (v/v), Merck, Darmstadt, Germany) was added to 
10 mL of the aliquot containing Group B soyasaponins which was suspended in aqueous 




C in a 
temperature controlled water bath and 120
o
C in an oven in sealed containers. After hydrolysis, 
the solution was diluted with water until the concentration of methanol was 50% and applied 
to Phenomenex 10 g C18 Sep-Pak cartridge which was pre-conditioned with deionised water. 
The cartridge was washed with water (200 mL) and the hydrolyzed solution was eluted with 
methanol (Gurfinkel, Reynolds et al. 2005). The hydrolysis was repeated again in anhydrous 
methanol as described above. 
6.2.3.3 ALKALINE HYDROLYSIS AQUEOUS AND ANHYDROUS MEOH  
The base hydrolysis of Group B soyasaponins was similar to the method described 
above for the acid hydrolysis but the acid was replaced by sodium hydroxide (5% (v/v) 
Merck, Darmstadt, Germany).  
6.2.3.4 HPLC ANALYSIS OF HYDROLYZED GROUP B SOYASAPONINS 
The HPLC system is described above and the mobile phase consisted of 0.05% 
trifluoroacetic acid (Merck, Darmstadt, Germany) in water (solvent A) and acetonitrile 
(solvent B). The flow rate of the mobile phase was 1 mL/min with the column temperature at 
25
o
C. The elution gradient conditions of the analysis of soyasaponins were as follows: 
solvent A was decreased from 60% to 52% over 60 minutes and the UV absorbance was set 
as 210nm (Lin and Wang 2004).  
6.2.3.5 LC-ELECTROSPRAY IONIZATION (ESI-MS) CONFIRMATION OF GROUP 
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B SOYASAPONINS 
LC/MS system and conditions are described above for the soyasaponins analysis with a 
the following changes: the column used was a Shimadzu reversed phase C-18, 5μm, 250 mm 
x 4.6 mm internal diameter and the source inlet temperature was set at 200
o
C. 
The mobile phases were 2.5% acetic acid (Merck, Darmstadt, Germany) in water 
(solvent A) and acetonitrile (solvent B) and the condition of elution was the same for the 
HPLC analysis of the hydrolyzed sample described above. 
6.2.3.6 SAMPLE VALIDATION  
The external standard calibration curves using soyasapogenol B authentic standard 
resulted in two equations corresponding to two different HPLC programs described above, 
they are y = 221451x - 700899 and y = 237234x + 89086 for total soyasaponins and 
soyasaponin I and III compound respectively and were linear over the concentration tested 
with square correlation coefficients of r
2 
= 0.991 for total soyasaponins and r
2 
= 0.994 for 
soyasaponin I and III compound. Both calibration plots of standards and samples were 
constructed by HPLC areas from triplicate injections. To investigate the accuracy of the 
method, three repeated analysis of sample including extraction procedure were performed to 
evaluate within-day variation, and two repeated analysis of samples including extraction 
procedure at two different days by two different laboratory personnel were performed to 
evaluate the day-to-day and person-to-person variation. Statistical analysis involved ANOVA 
testing with Tukey’s post hoc test of significant and a students paired t-test with significance 
judge at (p < 0.05). 
6.3 RESULTS AND DISCUSSION 
6.3.1 EXTRACTION METHODS COMPARISON 
All four extraction techniques tested were able to extract crude soyasaponins and 
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isoflavones founds in soy flour. The main compounds extracted were identified as isoflavones 
such as daidzin, glycitin, genistin and soyasaponins I, III, Be, g, a, g, a. Interestingly, 
when crude or total soyasaponins amounts were measured the Soxhlet extraction in methanol 
yielded significantly (p < 0.05) lower amount of soyasaponins compared to all other 
extraction techniques while room temperature stirring in methanol yielded significantly (p < 
0.05) higher amounts. Although room temperature extraction for 48 h yielded the greatest 
amount, the 48 h extraction was not found to be significantly different from 24 h extraction. 
The amounts of soyasaponins extract from lowest to highest were found to be Soxhlet < 
reflux < sonication < 24 h stirring room temperature < 48 h stirring (Figure 22). A difference 
of slightly greater than 70 mg of soyasaponins per 100 g soy flour were obtain from room 
temperature compared to Soxhlet extraction. The differences in the amount of total 
soyasaponins obtained from the different extraction techniques may be attributed to the 
presence of heat during the extraction process. Yang et al reported that increasing the 
temperature from 10 – 60°C increased the extraction yield of ultra sound assisted extraction 
of soy hypocotyls (Yang, Jin et al. 2007). These results presented herein indicated that 
applying heat to the extraction of soy flour during Soxhlet and reflux extraction likely caused 
deglycosylation of saponin glycosides compared to room temperature extraction. A similar 
finding was reported for ginseng saponins extracted in boiling water (Popovich and Kitts 
2004). The oleanane backboned structure is also prone to fragmentation and breaking during 
electron ionization MS analysis (Heftmann, Luudin et al. 1979)). Additional thermal energy 
would also transform the DDMP conjugated group B soyasaponins such as g into the 
corresponding non DDMP soyasaponin I (Okubo 1996). Alternatively room temperature 
extraction maximized the amount of DDMP-soyasaponins which can be useful for 






Fig 22. The effect of three different extraction techniques on total amount of soyasaponins 
recovered. Values are expressed as mean + SD, bars with different subscripts letters are 
significantly different (p < 0.05) from each other. Samples were extracted on three separate 
occasions and analyzed three times. Total soyasaponins were calculated based on the 
external soyasapogenol B standard described in the material and methods.  
 
6.3.2 COMPARISON OF SOYASAPONIN CONCENTRATION METHODS 
Soy isoflavones are the main interfering compounds during soyasaponins separation and 
analysis. In this study, three methods, liquid-liquid (butanol-water), ammonium sulphate (3M) 
and SPE (45% methanol) were tested to remove isoflavones with the aim of maximizing the 
amount of soyasaponins. Figure 23 shows the HPLC analysis of both the isoflavones and 





Fig 23. HPLC chromatographs of three different procedures to removed interfering 
isoflavones. Panel (a) utilized a butanol/water liquid-liquid extraction panel (b) shows the 
effect of ammonium sulfate (3M) precipitation and panel (c) employed a solid phase 
extraction (SPE) as described in the materials and methods. 
 
In this study I have utilized two HPLC gradient programs one to maximally resolve 
interfering isoflavones (Figure 23) and one designed to maximally resolve soyasaponins 
(Figure 24). Isoflavones daidzin, glycitin, genistin, acetyl-daidzin and acetyl-genistin were 
identified in this extract (Figure 23a) and molecular weight confirmed by mass spectrometry.  
The use of ammonium sulphate (3M) has been reported to help precipitate the soyasaponins 
(Gurfinkel, Reynolds et al. 2005) from the interfering compounds. However as the HPLC 
chromatograph in Figure 23b indicates that there was no major difference in the overall 
profile of the chromatograph of the isoflavones with the exception of acetyl-daidzin which 
was not detected and a reduction of the peak area associated with soyasaponins was noted. In 
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this study I have utilized a gradient SPE separation method directly from a crude methanol 
extract to maximize the soyasaponins and remove the isoflavone. A column wash with 
methanol (45%) was sufficient to virtually eliminate most of the competing isoflavones and 
resulted in the greatest amount of soyasaponins out of the three concentration methods tested. 
Figure 3c shows only a one small peak corresponding to acetly-genistin (< 1%) and an 
increase in peak area corresponding to soyasaponins was observed. SPE concentration was 
employed to further separate the soyasaponins in further experiments content herein. 
6.3.3 HYDROLYSIS OF GROUP B SOYASAPONINS 
By employing a gradient for the SPE concentration described above isoflavones were 
successfully removed from soyasaponins. One additional methanol (50%) wash was found to 
eliminate all group A soyasaponins which resulted in a concentrated extract of group B 
soyasaponins containing soyasaponins I, III, g, a, g and a (Figure 24a). Individual 
molecular weights were confirmed by LC/MS and are shown in Figure 5. The molecular ions 
of all seven group B soyasaponins were observed as [M+H]. The concentrated group B 
soyasaponins were further subjected to both acid and base hydrolysis at different 
environmental temperature conditions in both methanol and anhydrous methanol to determine 
the optimal conditions to produce soyasaponin I and III. 
I hoped to increase soyasaponins I and III by targeting the removal of the DDMP moiety 
from the structure without interfering with the glycosidic bond at position C3 of the structure. 
Figure 24 (b, c) shows that base hydrolysis provides a better control of the hydrolysis 







Fig 24. HPLC chromatograph of the group B soyasaponins panel (a) obtained from SPE 
(refer to Figure 23 panel c), followed by the removal of group A soyasaponins refer to the 
materials and methods. Panels b) and c) represent saponins following acid or alkaline 
hydrolysis described in the materials and methods.  
 
Alkaline hydrolysis (KOH) has been utilized for structure determination of soyasaponins 
(Kitagawa 1988) and partial alkaline hydrolysis (NaOH) to remove the DDMP moiety in 
order to quantify non DDMP soyasaponins has been utilized (Gu, Tao et al. 2002). Specially, 
Figure 25 shows that base hydrolysis in anhydrous methanol produced the greatest amounts 
or both soyasaponin I and III and showed a maximal amount at 80°C compared to acid 
hydrolysis. Anhydrous conditions have reported to produce the maximum amount of 
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authentic soyasapogenols A and B during complete methanolyzation (Ireland and Dziedzic 
1986).  
  
Fig 25. The effect of acid and base hydrolysis, environmental temperature and both methanol 
and anhydrous methanol on the generation of soyasaponin I and III is shown. The grey bar 
represents the amount before hydrolysis, open bar represents hydrolysis in a closed container 
in a 80°C water bath, hatched bars was hydrolysis at 100°C and solid bar was hydrolysis in a 
120°C dry oven. Values are expressed as mean + SD, bars with different subscripts letters are 
significantly different (p < 0.05) from each other of the same solvent group.  
 
In this chapter the amounts of soyasaponin I produced by anhydrous methanol alkaline 
 90 
hydrolysis increased the level of soyasaponin I by approximately 32 mg/100 g soy flour or a 
percentage increase of 175%. Soyasaponin III showed a similar result a 16 mg/100 g increase 
corresponding to 211% change. Interestingly, increasing environmental temperature had 
different effects on soyasaponin I and III during acid hydrolysis. Soyasaponin I significantly 
(p < 0.05) decreased as environmental temperature increased in both methanol and anhydrous 
methanol. Increased temperature significantly (p < 0.05) increased soyasaponin III in 
methanol but reached a maximum at 100°C. Analyzing the transition from DDMP conjugated 
groups B soyasaponins to non DDMP soyasaponins I and III is shown in Figure 26. 
Soyasapogenol B is prone to structural breakdown (Ireland and Dziedzic 1986).  
 
Fig 26. The appearance and disappearance of group B soyasaponins before (open bar) and 
after (solid bar) anhydrous alkaline hydrolysis outlined in the materials and methods. Bars 
with an asterisk(*) are significantly (p < 0.05) different then the corresponding pair. 
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Four DDMP group B soyasaponins g, a, g and a and unidentified peaks (Figure 24a) and 
soyasaponins I and III were monitored before and after base hydrolysis in anhydrous 
methanol. Soyasaponin I and III both significantly (p <0.05) increased compared to before 
hydrolysis while g, a, a and the unidentified peaks significantly (p < 0.05) decreased. 
Soyasaponin Be has been classified as a group E soyasaponin (Okubo 1996) but it is likely 
that group E soyasaponins are artifacts of hydrolysis of group B soyasaponins (Ireland and 
Dziedzic 1986). The exception was soyasaponin g which was not found to be significant but 
was also reduced. It is noteworthy that a, a, g were reduced to trace amounts or below 1% 
of peak area.  The increase in the HPLC peak area of soyasaponin I (51%) and III (24%) 
resulted in a net gain of 75% which nearly matches the reduction of Be (-4%), g (-44%), a 
(-16%), g (-3%), a (-1%) and unidentified peaks (-6%) of a loss of 74% of peak area. Thus 
alkaline anhydrous hydrolysis can increase both soyasaponins I and III from DDMP 
conjugated group B soyasaponins with out hydrolyzing the glycosidic bond at position C-3.  
6.4 CONCLUSION 
I have effectively shown that to maximize the extraction of soyasaponins utilizing room 
temperature extraction in methanol for 24 or 48 h would produce the maximum amount of 
saponins and the use of SPE effectively removed virtually all interfering isoflavones and 
increased the retention of soyasaponins. Anhydrous alkaline hydrolysis following a gradient 
SPE was effective to produce a concentrated extract consisting of primarily soyasaponin I 






CHAPTER 7 SEPARATION AND PURIFICATION OF 
SOYASAPOGENOL B UNDER OPTIMIZED HYDROLYSIS AND MASS 
SPECTROMETRY CONDITIONS 
Preface 
Selected portions of Chapter 7 have been published in the following publication 
Zhang, W. and D. G. Popovich (2010). “Separation and Purification of Soyasapogenol B 
under Optimized Hydrolysis and Mass Spec Conditions.” Food Chemistry, 123, 993-999 
7.1 INTRODUCTION 
I have reported in previous chapters that soyasaponins can influence the growth of 
cultured hepatocarcinoma cells and induce apoptosis (Chapter 3) and the effect are related to 
extraction conditions (Chapter 4). I have also reviewed the chemical and biological 
characterization of soyasaponins in the chapter 2.  
There have been numerous reports on the analysis of individual soyasaponins (Lin and 
Wang 2004; Berhow, Kong et al. 2006; Jin, Yang et al. 2006; Yang, Jin et al. 2007) in soy 
varieties and products. The aglycones are potentially more cytoactive than their 
corresponding glycoside moieties (Gurfinkel and Rao 2002; Kinjo, Hirakawa et al. 2003; 
Zhang and Popovich 2008). Hubert J at al. (Hubert, Berger et al. 2005) reported the analysis 
of soyasapogenol A and B together by HPLC –UV from a variety of soy products and 
Heftmann E at al. (Heftmann, Luudin et al. 1979) analyzed the two soyasapogenols by mass 
spectrometry, however both reports did not offer any incitations on a separation and 
purification method for the aglycones. In addition, a diagnostic fragmentation ion m/z at 234 
during the identification of soyasapogenol B has been observed to be a fragmentation 
equivalent to a reverse Diels-Alder reaction (Heftmann, Luudin et al. 1979). Ireland PA et al., 
(1987) (Ireland and Dziedzic 1987) suggested the ion at m/z 221 was a fragmentation ion of 
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soyasapogenol B1 (a possible artifact) due to the effect of the alternative Diels-Alder reaction. 
However, some possible fragmentations and transformations were likely affected by the 
hydrolysis environment and water in the sample that can produce other alternative 
fragmentation patterns and noise when analyzing soyasapogenols (Ireland and Dziedzic 
1986) . Moreover, both reports did not suggest a chemical scheme for the Diels-Alder 
reaction of soyasapogenol B during mass ionization and there are no further reports about MS 
analysis of soyasapogenol B since the reverse Diels-Alder reaction had been proposed. 
Therefore, the objective of this chapter was to optimize the hydrolysis conditions for 
releasing soyasapogenol B and capillary temperatures for mass spec analysis of 
soyasapogenol B. I also offer updating incitation into breakdown products during ESI-MS 
analysis procedure. 
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7.2 METHODS AND MATERIALS 
7.2.1 EXTRACTION AND ISOLATION OF GROUP B SOYASAPONINS FROM 
DEFATTED SOY FLOUR 
The extraction method is same as the Chapter 6 except that the samples were further 
diluted to 100 mL by 100% methanol and divided into 10 test samples with each containing 
10 mL for hydrolysis.  
7.2.2 HYDROLYSIS AT DIFFERENT TEMPERATURES  
Triplicate group B soyasaponins samples (10 mL) were hydrolyzed with 5% 






C for 1 hour in sealed 50 mL glass bottles. The 
rational of the selection of the acid has been based on the literature (Ireland and Dziedzic 
1986). After hydrolysis, the samples were diluted to 30% methanol with water which caused 
a precipitate to be formed. The precipitate was washed with water several times, recovered by 
centrifugation (750 g, 5 mins) and subsequently dissolved in 3 mL methanol. For maximum 
yield, the superstrata liquid which contained dissolved soyasaponins were loaded on SPE and 
washed by water (200 mL) and eluted by 100% methanol (27 mL).  
7.2.3 HPLC-ESI-MS ANALYSIS 
The HPLC system was the same as the Chapter 6. The flow-rate was 1.0 mL/min and the 
elution program was as listed: Time 0 (13% B), 3 min (40% B), 5 min (40% B), 15 min 
(100% B), 18 min (100% B), and 20 min (13% B). The PDA detection wavelength was 250 
nm. ESI-MS system was a Finnigan LCQ quadrupole ion trap MS with MS
n
. The capillary 
temperature was set at 250
o
C. Both the sample and standard were analyzed under full scan 
(100-1000 u) and SIM (457.4) mode. 
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The authentic standards of soyasapogenol B (APIN Chemicals, Abingdon, Oxon, UK) 
were used for quantification in the SIM mode and concentrations of 10 - 50 ppm were used to 
establish a standard curve and injections were preformed in triplicate. 




ESI-MS was used for studying the stability of soyasapogenols during the ionization 

























C and the MS system parameters was 
described as above. The spray current was 0.14 μA and spray voltage was 4.57 kv. The sheath 
gas flow rate was set at 40μL/min. ESI low flow method was used with 5 μL/min flow rate 
and the standard of soyasapogenol B was diluted to 5 ppm in methanol. The MS
n 
condition 
was the same as above described and the capillary temperature was set at 250
o
C. The energy 
for scattering the soyasapogenol B ion (457.4 + 1) was set at 50%.  
7.2.5 STATISTICAL METHODS 
A one way ANOVA was used to analyze the experimental data. Significance was judged 
at p < 0.05 using the Tukey post hoc multiple comparisons of observed means and a students 
paired t-test. 
7.2.6 METHOD VALIDATION 
The standard calibration curves equation was y = 137180x + 7×10
6
 for soyasapogenol B 
and was linear over the concentration tested with square correlation coefficients of r
2
 = 0.994. 
The calibration plot of standard and sample was constructed by plotting mean SIM peak area 
from triplicate injections. To investigate the accuracy of the method, three repeated analysis 
of sample including extraction procedure were performed to evaluate within-day variation, 
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and two repeated analysis of samples including extraction procedure at two different days by 
two different laboratory personnel were performed to evaluate the day-to-day and 
person-to-person variation. 
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7.3 RESULTS AND DISCUSSIONS 
7.3.1 THE EFFECT OF TEMPERATURE ON ACID HYDROLYSIS OF GROUP B 
SOYASAPONINS 
Table 8 lists the concentrations of soyasapogenol B released by acid hydrolysis of group 
B soyasaponins at three different temperatures. The hydrolysis conditions for yielding 
soyasapogenol B (using 5% HCl for 1 hour in a methanol environment) has been previously 
described by Ireland P.A. and Dziedzic S.Z. (Ireland and Dziedzic 1986).  
Table 8. The Effect of Temperature on the Acid Hydrolysis of Group B Soyasaponins. Results 
are expressed as mean ± SD of three replicate analyses. Columns with different superscript 
letters are significantly different (p < 0.05). However, the optimal temperature for acid 




C) Soyasapogenol B (μg/mL) 
80 46.54 ± 6.41
a
 
100 84.59 ± 4.73
b
 




Hubert J et al., (Hubert, Berger et al. 2005) reported using HCl to hydrolyze soyasaponins to 
soyasapogenols at 85 
o
C, while Gurfinkel et al., (Gurfinkel and Rao 2003) showed the results 
of using H2SO4 to hydrolyze samples at 120 
o
C. Our aim was to optimize the temperature for 
maximum soyasapogenol B hydrolysis. The maximum concentration of soyasapogenol B was 
detected at 100 
o
C followed by a significant (p < 0.05) reduction at 120 
o
C and the minimum 
concentration was observed at 80 
o
C. A possible explanation for this release patterns is that 
heating easily results in a transformation of soyasapogenol B to soyasapogenol B1 and C 
which are isomers of soyasapogenol B and are shown in Figure 27 (Ireland and Dziedzic 
1986; Oleszek 2002; Oleszek and Bialy 2006). Compared to soyasapogenol B, soyasapogenol 
B1 has a double-bond between C13 and C18 instead of the double-bond between C12 and 
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C13 and soyasapogenol C has a one more double-bond between C21 and C22. Ireland PA et 
al., (Ireland and Dziedzic 1986) also indicated the acid-catalyzed double-bond migration was 
observed during soyasaponins hydrolysis.  
 
Fig 27. Structures and molecular weights of soyasapogenol B, C and B1 
7.3.2 SAMPLE CALIBRATION  
Figure 28 shows the LC-MS analysis ion trace in SIM and full scan mode (negative 
mode) of both the commercial standard and the purified sample of soyasapogenol B 
generated by acid hydrolysis. The sample showed similar EI mass spectra and retention time 
to the standard. Acid hydrolysis of group B soyasaponins produced 25 mg/100 g of soy flour 







Fig 28. HPLC and LC-MS Chromatogram of standard and purified sample of soyasapogenol 
B. Panels (a and c) are authentic standard and samples of soyasapogenol B measured in 
HPLC and SIM mode with m/z values of 457.4 (negative) respectively, and panel b, d and e 
are samples analyzed in HPLC, full MS scan mode and SIM mode respectively. 
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7.3.3 CAPILLARY TEMPERATURE EFFECT OF ANALYZING SOYASAPOGENOL 
B 
Heftmann E et al. (Heftmann, Luudin et al. 1979) previously identified that the base 
peak in the mass spectra of soyasapogenol B was induced by a structurally diagnostic reverse 
Diels-Alder reaction which should produce mass fragments of 234. However, in this study, 
the ion fragment [M= 234] was not observed at any capillary temperatures, while the intact 
mass ion of soyasapogenol B ([M – H] – = 457.4) with different signal strengths were 
detected at different capillary temperatures and the result is shown in Figure 29. the highest 




C. In addition, ion at m/z 457.4 
([M – H] – ) became the dominant ion with highest relative abundance after the capillary 
temperature reached 220
o
C (table 2). Based on the above evidence and by comparison with 
the standard certification (the melt point of soyasapogenol B is 250
o
C), the best capillary 







Fig 29. Intensity of soyasapogenol B mass ion at different capillary temperatures. Bars with 





In general, soyasapogenols detection has been preformed by a variety of techniques, 
such as TLC with densitometery (Gurfinkel and Rao 2002), HPLC, NMR (Berhow, Cantrell 
et al. 2002; Berhow, Kong et al. 2006) and LC-MS analysis (Heftmann, Luudin et al. 1979). 
ESI-MS analysis, although powerful, has prevented detail analysis of soyasapogenols likely 
due to the chemical structure instability during ionization which leads to limited information 
of detectable intact molecular weight of the compounds (Heftmann, Luudin et al. 1979). 
Negative ions were most easily observed when methanol is used as solvents. The normal 
negative ion ESI mass spectrum of soyasapogenol B is characterized by the prominent 
deprotonated molecule [M – H]–, at m/z 457, as well as some fragments and dimer ions which 



















Fig 30. The mass spectrums of soyasapogenol B from 200 
o
C to 250 
o
C (M = 458, origanl soyasapogenol B molecular)
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    The main fragment ions observed under negative mode were m/z at 915, 441 and 217 at 
low capillary temperatures condition (< 220 
o
C), while ions m/z at 440 and 437 were detected 
at high capillary temperatures condition, generally above 220 
o
C. The ion m/z at 915 is a 
dimer (2[M – H] –) of soyasapogenol B. The ion at 441 likely relates to the loss of [-OH] 





Fig 31. Proposed fragmentation scheme of the ion m/z at 457.4 in negative mode. ① 
described by Hefrmann E., et al. (17); ② found from this study and proposed by Lee M.R., et 
al.(24); ③ and ④ found from this study. (M = 458, M is intact soyasapogneol B) 
 
This structure of ion m/z at 441 had been suggested by Lee et al. (Lee, Chen et al. 1999) 
during FAB-MS analysis for soyasaponin I from black bean (Vigna mungo L.Hepper). 
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Interestingly, the ion m/z at 217 might occur relating to the Diels-Alder reaction of the 
ion m/z at 441. However, based on the result obtained from MS/MS analysis of ion m/z 
at 457 (Figure 32), the ions m/z at 440 and 437 which appear only at high capillary 
temperatures likely because of the self-scatter and fragmentation of soyasapogenol B 
were identified.  
 
Fig 32. MS/MS spectrum of soyasapogenol B produced by negative ESI at 50% scatter 
energy 
7.4 CONCLUSION 
An optimized hydrolysis method to yield soyasapogenol B with relatively high purity 
and also provided an optimum MS detection method for analyzing soyasapogenol B was 
shown. In this study, a modified Diels-Alder revise reaction was found and provides a clearer 





CHAPTER 8 FERMENTATION OF GROUP B SOYASAPONINS WITH 
PROBIOTIC LACTOBACILLUS RHAMNOSUS 
Preface 
Selected portions of Chapter 8 have been submitted to the following 
Zhang, W., F. Y. Tang., M. C. Yeo and D. G. Popovich (2010). “Fermentation of Group B 
Soyasaponins with Probiotic Lactobacillus rhamnosus.” Journal of food Biochemistry, 
submitted and under reviewing. 
8.1 INTRODUCTION 
In chapters 3 and 6, differences in bioactive response of cultured hepatocarcinoma 
(Hep-G2) cells to group B soyasaponins and these differences are related to extraction 
conditions and composition were presented. The soyasapogenols have been reported to be 
more cytotoxic towards cultured cancer cells (Gurfinkel and Rao, 2003) compared to 
soyasaponin glycosides or DDMP conjugated soyasaponins (Chapter 4 and 5).  
Compared to isoflavones, the effects of fermentation on soyasaponin phytochemical 
biotransformation has received considerable less attention. Soyasaponins have been shown to 
convert from various glycosides forms of group A or B soyasaponins into the soyasapogenols 
by fermentation with human colonic microflora (Gurfinkel and Rao, 2003). Soyasaponin I, an 
abundant group B soyasaponin, has been reported to be transformed to structural related 
soyasaponin III after 24 h and soyasapogenol B after 48 h of incubation with human fecal 
microorganisms (Hu et al., 2004). Biotransformation of fermented soy products such as soy 
milk using probiotic lactic acid bacterial are thought to increase bioactive properties of soy. 
The enzymatic degradation of isoflavones by lactic acid bacteria has been reported to 
increase the availability of isoflavone aglycones and resulting bioactivity (Pyo et al., 2005). 
In this study, the probiotic bacteria strain Lactobacillus rhamnosus was chosen to study 
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the fermentation of group B soyasaponins. This lactic acid bacteria strain was selected due to 
its ability to proliferate in soymilk and expresses high level of β-glucosidase activity 
(Marazza et al., 2009). L. rhamnosus is able to hydrolyze β-glucoside isoflavones to its 
aglycones due to its β-glucosidase activity (Hubert et al., 2008). The objective of this study 
was to investigate the biological modification of the phytochemical profile of group B 
soyasaponins, without interfering isoflavones, fermented with probiotic lactic acid bacterial 
enzyme preparation from L. rhamnosus.  
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8.2 MATERIALS AND METHODS 
8.2.1 EXTRACTION OF SOYASAPONINS  
The extraction methods were described in the Chapter 3 (3.2).  
8.2.2 SOLID PHASE EXTRACTION AND ISOLATION OF GROUP B 
SOYASAPONINS 
Isolation of group B soyasaponins was described in the Chapter 5 (5.2). 
8.2.3 FERMENTATION OF GROUP B SOYASAPONINS 
M.R.S Broth (de man, Rogasa, Sharpe, Oxoid, England) was prepared according to the 
manufacturer’s instructions. M.R.S powder (52 g) was suspended in 1 L of distilled water at 
60 
o 
C and stirred. The M.R.S Broth was then dispensed into its final containers and sterilized 
by autoclaving at 121 
o 
C for 15 min.  
100 mM Potassium dihydrogen phosphate (KH2PO4) (Merck, Germany) and 100 mM 
dipotassium hydrogen phosphate (K2HPO4) (Kanto Chemical Co., Inc, Japan) were used in 
the preparation of the 100 mM phosphate buffer. The pH of the buffer was adjusted to 7.05, 
using a pH meter (Metrohm, Riverview, FL, USA). This pH was chosen as DDMP 
soyasaponins are thought to stable within a narrow pH range, with an optimal stability around 
pH 7 (Heng et al., 2006). The buffer was then sterilized by autoclaving at 121 
o 
C for 15 min. 
Lactobacillus rhamnosus HN001 (Howaru Rhamnosus, Danisco Singapore Pte Ltd, 
Singapore) (70 mg) were inoculated into 100 mL of sterile M.R.S broth. The L. rhamnosus 
bacteria were then grown in the sterile M.R.S broth for 20 h without agitation at 37 
o
C in an 
incubator. After 20 hours incubation, the mixture was stirred thoroughly and then kept in 1 
mL aliquots at -80
 o 
C until needed.  
 109 
8.2.4 ENZYME PREPARATION (LACTOBACILLUS RHAMNOSUS) 
An aliquot (9 mL) of the bacteria suspension was then propagated in 450 mL sterile 
M.R.S broth (2%, v/v). The broth containing the lactic acid bacteria was incubated at 37 
o
C 
for 48 h without agitation in an incubator. The crude enzyme extract was prepared according 
to the procedure as described (Bae et al., 2004) with some modifications. After the 48 h 
incubation, the bacterial suspension was then centrifuged (1500 g, 30 min) and was further 
suspended in 100 mM sterile phosphate buffer (135 mL) and is herein referred to as the 
enzyme preparation.  
8.2.5 TIME-COURSE FERMENTATION OF GROUP B SOYASAPONINS 
Lyophilized group B soyasaponin powder (10 mg) was added to 15 mL of the enzyme 
preparation. The mixture was then incubated at 37
o 
C for 60 h without agitation. This was 
repeated 9 times to establish the time course fermentation curve. The reaction time points 
selected were 1, 3, 5, 7, 12, 24, 36, 48 and 60 h. At each of the stipulated time points, the 
reaction was heat treated at 65
o 
C for 30 min to inactive the enzymes. The control consisted 
of 10 mg of lyophilized group B soyasaponin powder in 100 mM sterile phosphate buffer (15 
mL), without the enzyme extract. The incubation and pasteurization conditions were the same 
as the fermented sample.  
Each sample at the respective time points were loaded individually onto preconditioned 
Waters C-18 Sep-Pak cartridge (10 g) and washed with 50 mL deionised water to remove the 
buffer. The samples were then eluted with 30 mL HPLC-graded methanol and concentrated to 
10 mL for HPLC and LC-MS analysis.  
8.2.6 HPLC AND LC-ESI-MS ANALYSIS  
High-performance liquid chromatography (HPLC) was performed using a Waters 
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(Milford, MA, USA) 2695 Separation Module with Waters 2996 Photodiode Array (PDA) 
detector HPLC system. A C-18, 5 μm, 250 mm x 4.6 mm internal diameter reversed phase 
column was used (Phenomenex). The mobile phases and the gradient program were 
previously described in the Chapter 7 with some modifications and were as listed: Time 0 
(13% B), 5 min (40% B), 40 min (60% B), 41-43 min (100% B), 45 min (13% B). The 
detection wavelength was set at 203 nm and the percentage peak areas were integrated to 
determine the percentage of the individual soyasaponins present. The injection solutions 
(isolated group B soyasaponins extract, fermented group B soyasaponins and the controls) 
were filtered using a Millipore syringe filter (0.45 μm) prior to HPLC analysis. The authentic 
standards of soyasapogenol B (APIN Chemicals, Abingdon, Oxon, UK) were used for 
quantification and concentrations of 10 - 50 ppm were used to establish a standard curve. 
Samples were analysed using a ThermoFinnigan LCQ-ESI quadrapole ion trap LC-MS 
(Thermo Fisher Scientific, Waltham, MA, USA) system with a Surveyor HPLC system 
coupled to a Finnigan AS3000 auto-sampler all running on the Xcaliber 2.0 software system. 
The MS was run with the ESI probe in both the positive and negative modes. The same 
column was used for both HPLC and LC-MS analysis. The source inlet temperature was set 
at 250° C, with the sheath gas rate at 80 arbitrary units, and the sweep auxillary gas rate at 29 
arbitrary units. The MS data was collected from 100 to 1500 m/z. The mobile phase was 2% 
(v/v) glacial acetic acid, in deionized water (Solvent A) and 100% acetonitrile (Solvent B) 
using the same gradient program described above for HPLC analysis.  
8.2.7 STATISTICAL ANALYSIS 
All results presented in this study were repeated three times. The statistical differences 
were evaluated by paired sample t-test and one-way Anova with Tukey’s comparison of 
observed mean and p < 0.05 was considered significant. The external standard calibration 
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curve equation was y = 420036x - 2×10
6
 for soyasapogenol B and was linear over the 




8.3 RESULTS  
8.3.1 HPLC-ESI-MS  
Figure 33a shows the HPLC chromatogram of group B soyasaponins before 
fermentation. DDMP soyasaponins βg, βa, γg and γa and their non-DDMP soyasaponins 
counterparts I, III and Be and the aglycone soyasapogenol B were identified and their 
respective molecular weights confirmed by LC-MS (Chapter 6).  
 
Fig 33. HPLC spectra of Group B soyasaponins before (panel a) and after 60 h of 
fermentation (panel b) with Lactobacillus rhamnosus enzyme extracts.  
 
The recovery of group B soyasaponins from soy flour was determined to be 0.35 ± 0.1 
mg/100 mg per dry weight soy flour which falls within the range of 0.26–2.75 mg/100 mg 
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dry weight for group B soyasaponin reported in the literature (Shiraiwa et al., 1991). After 60 
h fermentation with the enzyme preparation, most of DDMP soyasaponins were converted to 
non-DDMP soyasaponins I, III and Be and soyasapogenol B (Figure 33b). HPLC analysis of 
the fermented sample, subjected to 60 h incubation period, also showed the presence of a new 
previously unknown artefact or metabolite, corresponding to a retention time of 8.742 min 
shown in the HPLC chromatogram (Figure 33b). LC-MS-ESI analysis of the unknown 
metabolite after 60 h fermentation is shown in Figure 34. The unknown compound was 
found to have a pseudo molecular ion of m/z 253 in positive mode. The proposed structure is 
also shown in Figure 34 and likely corresponds to a fragmentation product identified during 
MS analysis at high temperature (Heftmann et al., 1979).  
 
Fig 34. LC/MS-ESI spectra and proposed structure of artifact in negative ionization mode 
(m/z 253) produced after 60 h incubation with Lactobacillus rhamnosus enzyme extract. 




8.3.2 SOYASAPONINS BEFORE AND AFTER FERMENTATION 
Table 9 shows the changes in soyasaponin profiles before and during the 60 h of 
fermentation. DDMP soyasaponins βa and γa initial concentrations were 9.96 + 0.72 μg/mL 
and 7.65 + 0.67 μg/mL respectively and rapidly broken down during the early stages of 
fermentation.  
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Table 9. Group B Soyasaponins Before During Fermentation. SG-B: Soyasapogenol B; UK: Unknown compound, Tr: trace below 0.1 μg/mL 
or undetected. The concentrations of the same soyasaponin group at different fermentation time points with different superscript letters are 
significantly (Tukey, p < 0.05) different. The concentration of the same soyasaponin group during fermentation (1 – 60 h) with an asterisk (*) are 








6.24 + 0.10 
 




I III Be βg βa γg γa SG-B UK 
Incubation 
Time 






1h 10.91 + 0.18a* 7.52 + 0.38a* 13.01 + 0.38ab 6.46 + 0.20a* Tr 10.06 + 0.41a* Tr 7.76 + 0.03bd* Tr 
3h 10.04 + 0.07def* 6.80 + 0.57a* 14.18 + 1.34a 6.49 + 0.44a* Tr 9.50 + 0.32ab* Tr 7.68 + 0.14bd* Tr 
5h 9.90 + 0.02
bde*
 7.11 + 0.04
a*
 12.72 + 0.48
ab
 5.97 + 0.07
a*
 Tr 8.88 + 0.07
bc*
 Tr 6.64 + 0.20
c*
 Tr 
7h 9.65 + 0.04bd* 6.75 + 0.29a* 11.94 + 0.89b* 5.93 + 0.22a* Tr 8.43 + 0.37cd* Tr 7.69 + 0.07bd* Tr 
12h 10.10 + 0.23
ef*
 7.10 + 0.22
a*
 8.79 + 0.05
c*
 5.21 + 0.03
b*
 Tr 7.98 + 0.27
d*
 Tr 8.06 + 0.05
d*
 Tr 
24h 10.39 + 0.13
f*
 6.95 + 0.19
a*
 8.96 + 0.20
c*
 Tr Tr 6.64 + 0.21
e*
 Tr 7.39 + 0.29
b*
 Tr 
36h 9.64 + 0.32b* 6.69 + 0.28a* 8.17 + 0.14c* Tr Tr 6.07 + 0.03ef* Tr 7.80 + 0.26bd* Tr 
48h 10.16 + 0.07
ef*
 6.74 + 0.40
a*
 8.92 + 0.14
c*
 Tr Tr 5.72 + 0.22
fg*
 Tr 8.03 + 0.23
d*
 Tr 
60h 7.31 + 0.06g* 5.58 + 0.21b 8.78 + 0.18c* Tr Tr 5.26 + 0.02g* Tr 7.53 + 0.05b* 6.19 + 0.07 
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After 1 h of fermentation both βa and γa decreased to less 0.1 μg/mL or was undetectable. A 
significant (p < 0.05) reduction in soyasaponin βg also was initiated after 1 h of fermentation 
with a percentage reduction of 69.4%. After 24 h soyasaponin βg was reduced to trace levels. 
Soyasaponin γg was significantly (p < 0.05) reduced after 1 h of fermentation and with a 
percentage reduction of 31.4% at 1 h and 64.1% at 60 h. Corresponding to reductions in 
DDMP soyasaponins the concentration of non DDMP soyasaponin I significantly (p < 0.05) 
increased after 1 h of fermentation and reached a maximum concentration of 10.39 + 0.13 
μg/mL after 24 h which corresponded to a percentage increase of 66.5% relative to non 
fermented levels. Soyasaponin III was also significant (p < 0.05) increased by 36.8% at 24 h 
compared to no fermentation. The concentration of group B aglycone soyasapogenol B 
significantly (p < 0.05) increased from 5.27 + 0.06 μg/mL before fermentation to 8.06 + 0.05 
μg/mL, the maximum level (12 h) and was still elevated after 60 h (7.53 + 0.05 μg/mL) 
compared to no fermentation. Furthermore, the concentration of the new unknown metabolite 
increased and was only detected after 60 h of fermentation (6.19 + 0.07 μg/mL). 
8.3.3 STABILITY OF SOYASAPONINS WITH AND WITHOUT LACTOBACILLUS. 
Groups B soyasaponins have different levels of stability that are known to be dependent 
on many different conditions such as temperature, pH and solvents. The effect of 
fermentation conditions with and without the enzyme preparation on the phytochemical 
profile of the group B soyasaponin extract after 60 h is shown in Figure 35. DDMP 
soyasaponins (βg, βa, γg and γa) and soyasaponin Be were all significantly (p < 0.05) reduced 
after 60 h compared to both experimental conditions, with and without the lactobacillus 
enzyme preparation. However there were no significant differences noted after 60 h between 
the samples with and without the enzyme preparation which suggests that fermentation and 
enzyme inactivation (heat treated at 65
o 
C for 30 min) conditions alone can alter DDMP 
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soyasaponin composition. Furthermore the increase in concentration of soyasaponin I and II 
also were significantly (p < 0.05) greater compared to no fermentation however no significant 
differences were observed between fermentation conditions with and without the enzyme 
preparations. This is also noted for the increased in the new metabolite produced. It is 
noteworthy that soyasapogenol B was the only compound to show the greatest significant (p 
< 0.05) increase and was determined to be significantly (p < 0.05) greater than using no 
enzyme preparation. 
 
Fig 35. The changes in phytochemical profile of group B soyasaponins before fermentation 
(no fermentation), and with (sample fermentation) and without (control fermentation) 
Lactobacillus rhamnosus enzyme extract after 60 h incubation. Bars with different subscripts 
letters are significantly different (p < 0.05). 
8.3.4 THE EFFECT OF INCUBATION CONDITIONS ON SOYASAPONIN 
Figure 36 shows the effect of time on changes of the concentration of group B 
soyasaponin during the course of fermentation and in contrast to the effect of the incubation 




Fig 36. Time course evaluation of group B soyasaponins phytochemical profile over 60 h 
incubation periods at 37 °C with and without (control) the addition of Lactobacillus 
rhamnosus enzyme extracts. Panels a – f correspond to soyasapogenol B, soyasaponins I, III, 
Be, βg and g respectively.  
 
Incubation of group B soyasaponins from 0 h to 60 h resulted in changes in the DDMP 
conjugated soyasaponins βg and γg over time. Soyasaponin βg did not show any significant 
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(p < 0.05) difference with respect to control samples until 24 h when βg decreased to 
undetectable levels while βg control followed at 36 h. Soyasaponin γg was found to be 
significantly (p < 0.05) higher compared to corresponding control values until 24 h when no 
significant changes between enzyme and non enzyme control samples could be detected. 
Soyasaponin Be was determined to be significantly (p < 0.05) greater until 7 h then a 
significant (p < 0.05) decreased was noted at 48 h and 60 h compared to control. Soyasaponin 
I concentrations were variable and were significantly (p < 0.05) higher until 36 h where no 
significant difference was noted but subsequently found to be significantly (p < 0.05) reduced 
at 60 h. Similarly, soyasaponin III also was significantly (p < 0.05) elevated until 24 h 
compared to non enzyme control and significantly (p < 0.05) decreased by 60 h. It is 
noteworthy that the concentration of soyasapogenol B, was significantly (p < 0.05) greater 
compared to the control group at all time points tested and reached a maximum concentration 
at 12 h of incubation. 
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8.4 DISCUSSION 
Fermentation of soy and related products by lactic acid probiotic bacterial has the 
potential to increase the bioavailability of bioactive compounds (Chien et al., 2006; Wei et al., 
2007) by altering the phytochemical profile and inducing changes in the gastrointestinal tract 
bacterial populations conferring a benefit to the host (Bouhnik et al., 2004). Group B 
soyasaponins isolated from soy flour were incubated with lactic acid probiotic bacteria 
Lactobacillus rhamnosus enzyme extracts and resulted in changes to the typical 
phytochemical profile. A majority of DDMP conjugated soyasaponins βg, βa, γg and γa were 
found to be labile and the DDMP conjugation was removed. The loss of the DDMP moiety 
resulted in an increase in the corresponding group B soyasaponin I and III at various time 
points during the fermentation. It is noteworthy that the DDMP was not specifically removed 
solely by incubation with the enzyme preparation but was also influenced by the incubation 
conditions. DDMP soyasaponins are known to be heat labile and can be effected by many 
different parameters such as solvent extraction conditions (Chapter 6). I have previously 
reported that DDMP conjugated soyasaponins converted to soyasaponins I and III by mild 
alkaline hydrolysis (Chapter 6). DDMP moiety was reported to be cleaved to released maltol 
a derivative of the DDMP molecule by the lactic acid bacteria fermentation process (Hubert 
et al., 2008). However, this is first observation of the instability of DDMP during culture 
conditions without the bacterial enzyme preparation. This decline in DDMP soyasaponin 
could be attributed to the incubation temperature, pH, culture media composition or the 
temperature used to inactive the enzyme. It is also likely that the DDMP moiety would also 
be lost during in vivo digestion and intestinal conditions. Removal of DDMP moiety from 
soyasaponins (βg, βa, γg and γa) resulted in increased soyasaponin I and III. Soyasaponin I 
and III which are structurally related molecules with soyasaponin I having one additional 
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sugar moiety attached at position C-3 compared to soyasaponin III.  
The concentration of soyasapogenol B increased during the fermentation compared to no 
fermentation and compared to control without the enzyme preparation. Soyasaponins I and III 
are likely converted to soyasapogenol B by β-glucosidase activity of the lactic acid bacteria. 
Lactobacillus rhamnosus exhibits a high level of β-glucosidase activity (Marazza et al., 2009). 
Soyasapogenols A and B composition have been reported to be increased during the lactic 
acid bacteria fermentation resulting from the conversion from glycosolated soyasaponins into 
the aglycone and other unidentified structures (Hubert, Berger et al. 2008). It is noteworthy 
that biotransformations of group B soyasaponins occur at specific time points during the 
incubation. Depending on desired optimal phytochemical profile, endpoint analysis after 60 h 
of incubation results in a different phytochemical that would be obtained after selected time 
points such as 24 and 48 h. Specifically controlling the incubation time can result in a 
selective phytochemical profile to maximize the desired products. 
Biotransformation with lactic acid bacteria of the phytochemical profile of other saponin 
containing plants such as dammarane triterpenoids derived from ginseng have been reported. 
Ginsenoside Rh2 has been reported to be produced from biotransformation of structural 
related ginsenoside Rg3 after incubation with human fecal microflora (Bae et al., 2004). 
Furthermore, incubation of ginsenoside Rc with human fecal microflora produced a novel 
ginsenoside metabolite known as compound K with increased bioactive properties (Bae et al., 
2002). It is noteworthy that a metabolite with a pseudo molecular weight of 254 was detected 
after 60 hour of incubation of group B soyasaponins with the lactic acid bacteria enzyme 
preparation and this artefact of biotransformation showed similar characteristics to compound 
that has been reported relating to the break down in the oleanane triterpenoid structure 
(Heftmann et al., 1979).  
In addition, I speculate that the bioactivities of group B soyasaponins extracts will be 
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increased after the lactic acid fermentation process due to the increase in the availability and 
concentration of the aglycone soyasapogenol B as a result of the degradation of glycosidic 
soyasaponins by β-glucosidase. In previous chapters I suggested that lipophilic sapogenins 
are more bioactive than glycosidic soyasaponins. Several human studies have also reported 
that aglycones are absorbed more efficiently than their respective glycoside structures (Izumi 
et al., 2000). Moreover, the new metabolite produced from the fermentation process may also 
possess distinct bioactive properties. The results contain herein presents an alternative, as 
opposed to the use of chemical transformation, to achieve the structural modification of 
soyasaponins and the soyasaponin phytochemical profile for the production of probiotic soy 
functional food products.  
8.5 CONCLUSION   
A fermentation method to modify the group B soyasaponins phytochemical profile was 
developed. The DDMP soyasaponins were generally not specifically affected by the lactic 
acid enzyme activity and were influenced by the culture conditions alone. Soyasapogenol B 
was directly increased by lactic acid bacteria enzyme fermentation likely by deglycosolation 
of soyasaponins I and III. Further studies are needed to determine if changes to the 









CHAPTER 9 OVERALL CONCLUSIONS AND FUTURE STUDY 
In this project, I have successfully developed an extraction and isolation method to yield 
different soyasaponins and extracts. SPE offered a highly efficient method of concentrating 
and isolating soyasaponins from soy flour. Generally, total soyasaponins (TS) and group B 
soyasaponins (RE and RT), can be simply isolated by using column chromatography with 
different solvents elution. However, for specific soyasaponins such as soyasaponins I and III 
and their aglycones (SG-A and SG-B), utilizing an alkaline hydrolysis method is the preferred 
method. In this dissertation the optimal temperature, pH and solvent system were found to be 
the most important factors on controlling soyasaponins conversion.  
The roles of specific soyasaponins have the potential to reduce the growth of cultured 
human liver cancer Hep-G2. MTT assay showed that different soyasaponin groups have 
varied potency in inhibiting the growth of Hep-G2 cell, which is due to differences in their 
chemical structures. A majority of soyasaponins were found to induce apoptosis cell death. 
This was evident by utilizing three different apoptosis assays, cell cycle, multicaspase 
apoptosis detection and TUNEL assay. The polarities of soyasaponin were a contributing 
factor to apoptotic cell death. This was supported by evidence that such as the aglycones have 
stronger apoptosis inducing abilities than their glycones which was described in Chapter 3 
and different extracts that contained varying levels of group B soyasaponins have different 
effects on Hep-G2 cells (Chapter 4). In addition, soyasaponins with less sugar conjugations 
have great cytotoxicity on Hep-G2 cells growth and strong ability to induce apoptosis. This is 
likely due to selective permeability of cell membrane which may allow some small molecules 
to access cells. Permeability depends mainly on the electric charge of the molecule and to a 
lesser extent the molar weight of the molecule. Electrically neutral and small molecules pass 
the membrane easier than charged and large ones. However further research is warranted to 
confirm this observation 
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In the future study, there are several research areas that need further study, and they are 
shown in the following paragraphs. 
Further investigation on the relationship between chemical structures and bioactivities of 
Group B soyasaponins is warranted as some new mechanisms may be involved in preventing 
or reducing cancer cell metastasis other than inhibition of cancer cell growth. Because of the 
biological difference between two Group B extracts shown in this thesis, I propose that 
modifying soyasaponins structures may lead to different bioactivities. Moreover, glycosidic 
soyasaponins might lose their terminal sugars due to enzymatic hydrolysis during LAB 
fermentation and might be converted into other unidentified structures. However, the detailed 
information of the new compound and modified soyasaponins are still not clear and even 
their bioactivities are also still unknown. Thus, modifying the structures of soyasaponins by 
biological methods to increase their bioactivities is an intriguing area for future research. The 
MTT assay, cell cycle analysis and morphological evaluation at every single fermentation 
time point can be used for building a cell death detection mode in order to fully understand 
how the evolution of the composition and chemical structure of Group B soyasaponins during 
the fermentation periods can influence their bioactivity. 
Soyasaponins have been reported to possess many bioactivities, which provide evidence 
of the need to create a health promoting food product with detailed bioactive properties. In 
the future study, isolation of soyasaponins with high purity is a priority and applying 
soyasaponins as food additives to some beverages is an interesting future research and 
application area.  
In this thesis, the focus was on total soyasaponins, group B soyasaponins and their 
aglycones. However, there is another group of soyasaponins known as group A that also may 
be biologically active. Far less evidence is available for group A compared to group B 
soyasaponins. Group A soyasaponins have more complicated structures and greater polarity 
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than group B. In the chapter 4, I found that soyasapogenol A had most strong cytotoxicity 
than any other two groups. Thus, I propose that group A soyasaponins may show more 
varieties of bioactivities compared to group B. However this remains to be established.   
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2. Tunel Apoptosis Assay Mechanism 
 
In the TUNEL assay which was described in the thesis, terminal deoxynucleotidyl transferase 
(TdT) catalyzes the incorporation of BrdU residues into the fragmenting nuclear DNA at the 
3’-hydroxyl ends by nicked end labeling. FITC-conjugated anti-BrdU antibody binds to the 
incorporated BrdU residues, labeling the apoptotic cells. Fluorescein isothiocyanate (FITC) is 
a derivative of fluorescein used in wide-ranging applications including flow cytometry. In this 
assay, FITC has been bind into anti-BrdU antibody, thus it can selectively tag the apoptotic 
cells when the antibody is binding to the apoptotic cells. 
 
 
